Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1O-15 Water[1] Water[1] Water 💬 --[1] 6 💬
2O2, gas for medical purposes----[1] 211 💬
3Oat[1] Oat---[1] 46 💬
4Oat bran (dietary fiber)[1] Oat---[1] 46 💬
5OATD-01----[1] 84 💬
6Oats----[1] 97 💬
7OAV101----[1] 3 💬
8Obatoclax[1] Obatoclax[1] Obatoclax mesylate 💬 [1] BCL2 💬 [40] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬[1] 60 💬
9Obatoclax mesylate (GX15-070MS)[1] Obatoclax[1] Obatoclax mesylate 💬 [1] BCL2 💬 [40] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬[1] 60 💬
10Obecabtagene autoleucel[1] Obecabtagene autoleucel[1] Obecabtagene autoleucel 💬 [1] CD19 💬 [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[2] 13, 49 💬
11Obecabtagene autoleucel (obe-cel)[1] Obecabtagene autoleucel[1] Obecabtagene autoleucel 💬 [1] CD19 💬 [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[2] 13, 49 💬
12Obefazimod[1] Obefazimod[1] Obefazimod 💬 [3] NCBP1,
NCBP2,
NCBP2L 💬 		[4] Amyotrophic lateral sclerosis, Nucleocytoplasmic transport, Spliceosome, mRNA surveillance pathway 💬[2] 96, 97 💬
13Obeticholic Acid[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[3] 93, 265, 296 💬
14Obeticholic Acid (OCA)[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
15Obeticholic Acid 10 MG[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
16Obeticholic Acid 5 MG[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
17Obeticholic Acid Tablets[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
18Obeticholic Acid Tablets(OCA)[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
19Obexelimab[1] Obexelimab[1] Obexelimab 💬 [1] CD19 💬 [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[4] 13, 49, 61, 300 💬
20OBI-1----[1] 288 💬
21OBICETRAPIB[1] Obicetrapib[1] Obicetrapib 💬 [1] CETP 💬 [1] Cholesterol metabolism 💬[1] 79 💬
22Obinutuzumab[1] Obinutuzumab[1] Obinutuzumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[6] 43, 44, 49, 63, 222, 223 💬
23Obinutuzumab administration[1] Obinutuzumab[1] Obinutuzumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[2] 49, 222 💬
24Obinutuzumab Injection[1] Obinutuzumab[1] Obinutuzumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 222 💬
25Obinutuzumab Injection [Gazyva][1] Obinutuzumab[1] Obinutuzumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 63 💬
26OBINUTUZUMAB/ GA101[1] Obinutuzumab[1] Obinutuzumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 222 💬
27Obitunuzumab----[1] 222 💬
28OBIZUR----[1] 288 💬
29Observational study----[2] 46, 271 💬
30Observational study to examine safety, tolerability, and effectiveness of SPINRAZA® prescribed as part of standard of care----[1] 3 💬
31Observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi----[1] 86 💬
32Obyoctocog alfa----[1] 288 💬
33OC oral solution treatment A----[1] 6 💬
34OC oral solution treatment B----[1] 6 💬
35OC oral solution treatment C----[1] 6 💬
36OC oral solution treatment D----[1] 6 💬
37OC000459----[1] 98 💬
38OC3----[1] 234 💬
39OC3 (buffer)----[1] 234 💬
40OC5----[1] 234 💬
41OC5 (enteric coated capsules)----[1] 234 💬
42OC5 (enteric-coated capsules)----[1] 234 💬
43OCA----[3] 93, 94, 296 💬
44OCA (INT-747)----[1] 93 💬
45OCA 0.1 mg----[1] 296 💬
46OCA 0.1mg----[1] 296 💬
47OCA 1,5 mg----[1] 94 💬
48OCA 1.5mg----[1] 296 💬
49OCA 5 mg----[1] 94 💬
50OCA 5mg----[1] 296 💬
51OCA, INT-747----[1] 93 💬
52Ocaliva----[2] 93, 296 💬
53Ocaliva 10mg----[1] 93 💬
54Ocaliva 5mg----[1] 93 💬
55Occlusive non adherent dressing----[1] 36 💬
56OCH-NCNP1----[1] 13 💬
57Oclelizumab----[1] 13 💬
58OCR----[1] 13 💬
59OCR SC----[1] 13 💬
60Ocrelizumab[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[4] 11, 13, 46, 49 💬
61Ocrelizumab (CinnaGen, Iran)[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
62Ocrelizumab (EU)[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
63Ocrelizumab (Roche, Switzerland)[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
64Ocrelizumab (US)[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
65Ocrelizumab / rhuMAb 2H7[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
66Ocrelizumab 300 mg[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
67Ocrelizumab 300mg[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
68Ocrelizumab 300mg /10ml[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
69Ocrelizumab 300mg/10 ml[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
70Ocrelizumab 300mg/10ml[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
71Ocrelizumab 500mg[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
72Ocrelizumab 600 mg[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
73Ocrelizumab at home[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
74Ocrelizumab co-formulated with rHuPH20[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
75Ocrelizumab Dose 1[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
76Ocrelizumab Dose 2 and Dose 3[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
77Ocrelizumab Injection [Ocrevus][1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
78Ocrelizumab IV[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
79Ocrelizumab Reference Formulation[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
80Ocrelizumab SC[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
81Ocrelizumab Test Formulation[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
82Ocrelizumabu 200mg----[1] 46 💬
83Ocrelizumabu 50mg----[1] 46 💬
84OCREVUS----[1] 13 💬
85Ocrevus 300 mg, solution à diluer pour perfusion----[1] 13 💬
86Ocrevus-EU----[1] 13 💬
87Ocrevus-US----[1] 13 💬
88OcrevusPharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: OcrelizumabCAS Number: 637334-45-3Current Sponsor code: RO4964913Other descriptive name: OCRELIZUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 30-Pharmaceutical form of the placebo: Concentrate for solution for infusionRoute of administration of the placebo: Intravenous useTrade Name: GilenyaPharmaceutical Form: Capsule, hardINN or Proposed INN: FingolimodCAS Number: 162359-55-9Current Sponsor code: RO7079904Other descriptive name: FINGOLIMODConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 0.5-Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral use----[1] 13 💬
89Ocrevus®----[1] 13 💬
90OCRH----[2] 75, 232 💬
91Ocrrelizumab 300 mg----[1] 13 💬
92OCTA-C1-INH----[1] 65 💬
93OctaAlpha1----[1] 231 💬
94Octagam----[2] 13, 65 💬
95Octagam 10%----[3] 50, 63, 65 💬
96Octagam 5%----[2] 13, 65 💬
97Octagam 50 mg/ml----[1] 13 💬
98OCTAGAM 50 mg/ml oldatos infúzió----[1] 65 💬
99Octagam® 10%----[1] 63 💬
100Octanorm----[2] 50, 65 💬
101Octanorm 16.5%----[2] 50, 65 💬
102Octaplas----[1] 64 💬
103Octaplas infusion----[1] 64 💬
104Octaplas SD----[1] 64 💬
105OctaplasLG®----[1] 64 💬
106Octaplas®LG----[1] 64 💬
107Octeotride----[1] 67 💬
108Octostim----[2] 64, 288 💬
109Octreolin----[1] 77 💬
110Octreotid----[1] 77 💬
111OCTREOTIDA[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
112OCTREOTIDA ACETATO[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
113Octreotidacetat----[1] 77 💬
114Octreotide[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[8] 67, 75, 77, 84, 85, 89, 193, 227 💬
115Octreotide a azione pronta 0,1 mg[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 227 💬
116OCTREOTIDE ACETATE[2] Acetate,
Octreotide		[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 77, 227 💬
117Octreotide acetate 30 mg suspension[2] Acetate,
Octreotide		[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
118Octreotide acetate and cabergoline/Octrotide and Somavert[3] Acetate,
Cabergoline,
Octreotide		[6] Octreotide ,
Cabergoline ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[3] DRD2,
PRL,
SSTR2 💬 		[16] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 77 💬
119Octreotide acetate LAR[2] Acetate,
Octreotide		[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
120Octreotide Acetate Microspheres for Injection injection[2] Acetate,
Octreotide		[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
121Octreotide acetate prolonged release, 30 mg[2] Acetate,
Octreotide		[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
122OCTREOTIDE ACETATO[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 77, 227 💬
123Octreotide capsules[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
124Octreotide FluidCrystal® injection depot[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
125OCTREOTIDE HYDROCHLORIDE[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
126Octreotide Implant[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
127Octreotide LAR[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 67, 77, 227 💬
128Octreotide LAR / Sandostatin LAR (LAR=long acting release)[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 84 💬
129Octreotide LAR 30 MG Injection[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
130Octreotide LAR 30mg[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
131Octreotide subcutaneous depot[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
132Octreotide-LAR[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 67, 77 💬
133Octreotide-LAR or lanreotide[2] Lanreotide,
Octreotide		[6] Octreotide ,
Octreotide acetate ,
Lanreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
134OCU400[1] OCU400---[1] 90 💬
135OCU400 High Dose[1] OCU400---[1] 90 💬
136OCU400 Low Dose[1] OCU400---[1] 90 💬
137OCU400 Med Dose[1] OCU400---[1] 90 💬
138OCU400 Second Eye Dosing[1] OCU400---[1] 90 💬
139OCU410ST[1] OCU410ST---[1] 301 💬
140Ocufolin----[1] 13 💬
141OD-07656----[3] 96, 97, 110 💬
142Odevixibat[1] Odevixibat[2] Odevixibat ,
Odevixibat hydrate 💬 		[1] SLC10A2 💬 [1] Bile secretion 💬[3] 296, 297, 338 💬
143OdevixibatProduct Code: A4250Pharmaceutical Form: Capsule, hardINN or Proposed INN: OdevixibatCAS Number: 501692-44-0Current Sponsor code: A4250Other descriptive name: A4250Concentration unit: µg microgram(s)Concentration type: equalConcentration number: 200-Product Name: OdevixibatProduct Code: A4250Pharmaceutical Form: Capsule, hardINN or Proposed INN: OdevixibatCAS Number: 501692-44-0Current Sponsor code: A4250Other descriptive name: A4250Concentration unit: µg microgram(s)Concentration type: equalConcentration number: 400-Product Name: OdevixibatProduct Code: A4250Pharmaceutical Form: Capsule, hardINN or Proposed INN: OdevixibatCAS Number: 501692-44-0Current Sponsor code: A4250Other descriptive name: A4250Concentration unit: µg microgram(s)Concentration type: equalConcentration number: 600-Product Name: OdevixibatProduct Code: A4250Pharmaceutical Form: Capsule, hardINN or Proposed INN: OdevixibatCAS Number: 501692-44-0Current Sponsor code: A4250Other descriptive name: A4250Concentration unit: µg microgram(s)Concentration type: equalConcentration number: 1200-----[1] 297 💬
144Odiparcil[1] Odiparcil---[1] 19 💬
145ODM-101----[1] 6 💬
146ODM-101 105mg Carbidopa[1] Carbidopa[1] Carbidopa 💬 [1] DDC 💬 [8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
147ODM-101 65mg Carbidopa[1] Carbidopa[1] Carbidopa 💬 [1] DDC 💬 [8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
148ODM-104----[1] 6 💬
149ODM-109----[1] 2 💬
150ODM-109 capsule 1 mg----[1] 2 💬
151ODSH at 0.125 mg/kg/h----[1] 210 💬
152ODSH at 0.250 mg/kg/h----[1] 210 💬
153ODSH at 0.375 mg/kg/h----[1] 210 💬
154Oestrogen----[1] 78 💬
155Ofatumumab[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[6] 11, 13, 35, 46, 222, 223 💬
156Ofatumumab 100[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
157Ofatumumab 300[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
158Ofatumumab 30mg[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
159Ofatumumab 3mg[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
160Ofatumumab 60mg[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
161Ofatumumab 700[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
162Ofatumumab approved dose[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
163Ofatumumab new dose[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
164Ofatumumab subcutaneous injection[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[2] 13, 35 💬
165Ofatunumab----[1] 13 💬
166Ofev----[5] 51, 85, 89, 227, 228 💬
167Ofev 100 mg capsule----[1] 85 💬
168Ofev 150 mg capsule----[1] 85 💬
169Ofev®----[2] 51, 85 💬
170OFF Dopaminergic Medication----[1] 6 💬
171Off-label compassionate drug use----[1] 21 💬
172OGT 918----[2] 19, 299 💬
173OGT918----[1] 19 💬
174OGT923----[1] 19 💬
175OGTT----[1] 77 💬
176OK432----[1] 278 💬
177Okrido----[1] 3 💬
178Okrido 6mg/mL oral solution----[1] 3 💬
179Oksikodoni----[1] 70 💬
180OKZ q4w----[1] 107 💬
181OL adalimumab 40 mg[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 96 💬
182OL-108----[2] 49, 51 💬
183OL-CD19-GDT----[2] 51, 53 💬
184OLANZAPINE[1] Olanzapine[2] Olanzapine ,
Olanzapine pamoate 💬 		[11] ADRA1A,
ADRA1B,
ADRA1D,
DRD2,
DRD3,
DRD4,
HRH1,
HTR2A,
HTR2B,
HTR2C,
HTR6 💬 		[18] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 2, 8 💬
185Olaparib[1] Olaparib[1] Olaparib 💬 [2] PARP1,
PARP2 💬 		[5] Apoptosis, Base excision repair, Diabetic cardiomyopathy, NF-kappa B signaling pathway, Necroptosis 💬[2] 86, 285 💬
186OLE BSA Adalimumab +/- MTX[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 107 💬
187OLE FD Adalimumab +/- MTX[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 107 💬
188Oleic Acid[1] Oleic Acid[1] Oleic acid 💬 --[2] 13, 299 💬
189Oleic acid supplementation[1] Oleic Acid[1] Oleic acid 💬 --[1] 299 💬
190OLENASUFLIGENE RELDUPARVOVEC[1] Olenasufligene relduparvovec---[1] 19 💬
191Oleogel-S10[1] Birch bark extract[1] Birch triterpenes 💬 --[1] 36 💬
192Oleovit D3 14.400 IU/ml oral drops, solution----[1] 13 💬
193Olesoxime[1] Olesoxime[1] Olesoxime 💬 --[3] 2, 3, 13 💬
194Olesoxime (TRO19622)[1] Olesoxime[1] Olesoxime 💬 --[1] 13 💬
195Oliceridine[1] Oliceridine[1] Oliceridine 💬 [3] ARRB1,
ARRB2,
OPRM1 💬 		[15] Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Dopaminergic synapse, Endocytosis, Estrogen signaling pathway, GnRH secretion, Hedgehog signaling pathway, Hormone signaling, MAPK signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Relaxin signaling pathway 💬[2] 46, 70 💬
196Oligofructose enriched inulin[1] Inulin[1] Inulin 💬 --[1] 96 💬
197Oligofructose-enriched Inulin OI[1] Inulin[1] Inulin 💬 --[1] 97 💬
198OligoG----[1] 299 💬
199OligoG (60 mg/ml)----[1] 299 💬
200OLIGOG CF-5/20----[1] 299 💬
201OligoG CF-5/20 - 17.5 mg----[1] 299 💬
202OligoG CF-5/20, 17,5 mg, Hartkapsel mit Pulver zur Inhalation----[1] 299 💬
203OligoG CF/20 - 27.5 mg----[1] 299 💬
204OligoG CF/20 - 37.5 mg----[1] 299 💬
205OligoG CF/20, 27,5 mg, Hartkapsel mit Pulver zur Inhalation----[1] 299 💬
206OligoG CF/20, 37,5 mg, Hartkapsel mit Pulver zur Inhalation----[1] 299 💬
207OligoG DPI----[1] 299 💬
208OligoG-CF5/20, Alginate oligosaccharide (G-block) fragment----[1] 299 💬
209Oligomer of Sodium Alginate[1] Alginic acid[2] Alginic acid ,
Sodium alginate 💬 		--[1] 299 💬
210Oligomero morfolino fosforodiamidato per skipping dell’esone 45----[1] 113 💬
211Oligomero morfolino fosforodiamidato per skipping dell’esone 53----[1] 113 💬
212Olikizumab----[1] 46 💬
213Olimel Parenteral Nutrition----[1] 97 💬
214OLIPUDASE ALFA[1] Olipudase alfa[1] Olipudase alfa 💬 [1] SMPD1 💬 [4] Lysosome biogenesis, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬[1] 19 💬
215Olipudase alfa (GZ402665)[1] Olipudase alfa[1] Olipudase alfa 💬 [1] SMPD1 💬 [4] Lysosome biogenesis, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬[1] 19 💬
216Olipudase alfa (rhASM)[1] Olipudase alfa[1] Olipudase alfa 💬 [1] SMPD1 💬 [4] Lysosome biogenesis, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬[1] 19 💬
217Olive oil[1] Olive oil[1] Olive oil 💬 --[10] 13, 34, 35, 46, 49, 53, 97, 124, 162, 271 💬
218Olmesartan[1] Olmesartan[2] Olmesartan medoxomil ,
Olmesartan 💬 		[1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 57, 223 💬
219Olmesartan medoxomil[1] Olmesartan[2] Olmesartan medoxomil ,
Olmesartan 💬 		[1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 57, 223 💬
220Olokizumab[1] Olokizumab[1] Olokizumab 💬 [1] IL6 💬 [49] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬[2] 46, 96 💬
221Olokizumab (OKZ)[1] Olokizumab[1] Olokizumab 💬 [1] IL6 💬 [49] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬[1] 96 💬
222Olokizumab 120 mg[1] Olokizumab[1] Olokizumab 💬 [1] IL6 💬 [49] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬[1] 46 💬
223Olokizumab 240 mg[1] Olokizumab[1] Olokizumab 💬 [1] IL6 💬 [49] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬[1] 46 💬
224Olokizumab 60 mg[1] Olokizumab[1] Olokizumab 💬 [1] IL6 💬 [49] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬[1] 46 💬
225Olokizumab 64 mg SC q2w[1] Olokizumab[1] Olokizumab 💬 [1] IL6 💬 [49] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬[1] 46 💬
226Olokizumab 64 mg SC q4w[1] Olokizumab[1] Olokizumab 💬 [1] IL6 💬 [49] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬[1] 46 💬
227Olokizumab 64mg q2w[1] Olokizumab[1] Olokizumab 💬 [1] IL6 💬 [49] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬[1] 46 💬
228Olokizumab 64mg q4w[1] Olokizumab[1] Olokizumab 💬 [1] IL6 💬 [49] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬[1] 46 💬
229Olsalazine[1] Olsalazine[2] Olsalazine sodium ,
Olsalazine 💬 		--[1] 271 💬
230Olumiant----[9] 46, 49, 93, 107, 135, 265, 268, 325, 345 💬
231Olumiant - EU/1/16/1170/001-008----[1] 49 💬
232Olumiant - EU/1/16/1170/009-016----[1] 49 💬
233Olumiant 2 mg/4 mg Filmtabletten----[1] 46 💬
234OLUMIANT 4 mg----[1] 46 💬
235OLUMIANT 4mg----[2] 46, 50 💬
236OLUMIANT® 2 mg comprimés pélliculés----[1] 50 💬
237Oluminant----[1] 107 💬
238OM 89.----[1] 46 💬
239OM336----[2] 61, 63 💬
240Omacor----[1] 49 💬
241Omadacycline[1] Omadacycline[2] Omadacycline ,
Omadacycline tosylate 💬 		--[1] 299 💬
242Omadacycline Injection [Nuzyra][1] Omadacycline[2] Omadacycline ,
Omadacycline tosylate 💬 		--[1] 299 💬
243Omadacycline Oral Tablet [Nuzyra][1] Omadacycline[2] Omadacycline ,
Omadacycline tosylate 💬 		--[1] 299 💬
244OMALIZUMAB[1] Omalizumab[1] Omalizumab 💬 [1] FCER1A 💬 [4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[7] 46, 53, 65, 98, 162, 226, 299 💬
245Omalizumab (Xolair)[1] Omalizumab[1] Omalizumab 💬 [1] FCER1A 💬 [4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[1] 65 💬
246Omaveloxolone[1] Omaveloxolone[1] Omaveloxolone 💬 [1] NFE2L2 💬 [7] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬[1] 18 💬
247Omaveloxolone Capsules, 10 mg[1] Omaveloxolone[1] Omaveloxolone 💬 [1] NFE2L2 💬 [7] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬[1] 18 💬
248Omaveloxolone Capsules, 150 mg[1] Omaveloxolone[1] Omaveloxolone 💬 [1] NFE2L2 💬 [7] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬[1] 18 💬
249Omaveloxolone Capsules, 160 mg[1] Omaveloxolone[1] Omaveloxolone 💬 [1] NFE2L2 💬 [7] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬[1] 18 💬
250Omaveloxolone Capsules, 2.5 mg[1] Omaveloxolone[1] Omaveloxolone 💬 [1] NFE2L2 💬 [7] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬[1] 18 💬
251Omaveloxolone Capsules, 20 mg[1] Omaveloxolone[1] Omaveloxolone 💬 [1] NFE2L2 💬 [7] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬[1] 18 💬
252Omaveloxolone Capsules, 300 mg[1] Omaveloxolone[1] Omaveloxolone 💬 [1] NFE2L2 💬 [7] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬[1] 18 💬
253Omaveloxolone Capsules, 40 mg[1] Omaveloxolone[1] Omaveloxolone 💬 [1] NFE2L2 💬 [7] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬[1] 18 💬
254Omaveloxolone Capsules, 5 mg[1] Omaveloxolone[1] Omaveloxolone 💬 [1] NFE2L2 💬 [7] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬[1] 18 💬
255Omaveloxolone Capsules, 80 mg[1] Omaveloxolone[1] Omaveloxolone 💬 [1] NFE2L2 💬 [7] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬[1] 18 💬
256OMB157----[1] 13 💬
257OMB157G----[1] 13 💬
258Omega 3 fatty acid----[1] 53 💬
259Omega 3 fatty acids----[1] 13 💬
260Omega 3 Premium----[1] 299 💬
261Omega-3----[3] 46, 49, 79 💬
262Omega-3 and Vitamin E supplementation[1] Vitamin E[1] Vitamin E 💬 --[1] 46 💬
263Omega-3 fatty acid----[1] 46 💬
264Omega-3 fatty acid ethylester90----[1] 66 💬
265Omega-3 Fatty Acid Fish Oil Supplement[1] Fish oil---[1] 66 💬
266Omega-3 fatty acids[1] Omega-3 fatty acids---[4] 13, 49, 79, 223 💬
267Omega-3 Fatty Acids (EPA plus DHA)[1] Omega-3 fatty acids---[1] 49 💬
268Omega-3 Supplementation----[1] 46 💬
269Omega-3 triglycerides----[1] 299 💬
270OMEGA-3-ACID TRIGLYCERIDES----[1] 299 💬
271Omegaven----[1] 96 💬
272Omegaven (10% fish-oil emulsion----[1] 46 💬
273Omegaven 10%----[1] 96 💬
274Omeprazol[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[2] 96, 294 💬
275Omeprazole[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[18] 6, 8, 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
276Omeprazole (proton pump inhibitor)[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 96 💬
277Omeprazole (UK licensed generic product)[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 85 💬
278Omeprazole 20 mg[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[2] 96, 97 💬
279Omeprazole 20 MG Oral Tablet[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 98 💬
280Omeprazole 20mg[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 51 💬
281Omeprazole 20mg BID[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 98 💬
282Omeprazole 20mg Capsule[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 299 💬
283Omeprazole 40 mg[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 96 💬
284Omeprazole Enteric Capsules[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 46 💬
285Omeprazole Enteric-coated Tablets[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 67 💬
286OMEPRAZOLE MAGNESIUM[2] Magnesium,
Omeprazole		[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 225 💬
287Omeprazole rectally 1mg/kg[1] Omeprazole[3] Omeprazole ,
Omeprazole sodium ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 294 💬
288Omidubicel[1] Omidubicel[1] Omidubicel 💬 [1] CD34 💬 [2] Cell adhesion molecule (CAM) interaction, Hematopoietic cell lineage 💬[1] 60 💬
289Omidubicel (former CordIn)[1] Omidubicel[1] Omidubicel 💬 [1] CD34 💬 [2] Cell adhesion molecule (CAM) interaction, Hematopoietic cell lineage 💬[1] 60 💬
290Omigapil[1] Omigapil---[1] 113 💬
291Omnidirectional accelerometer monitor (3x3 cm and 16 g, Actical®, Philips Respironics)----[1] 118 💬
292OMNIPAQUE----[2] 19, 222 💬
293OMNIPAQUE - 300 MG I/ML SOLUZIONE INIETTABILE FLACONE IN POLIPROPILENE DA 50 ML----[1] 222 💬
294OMNITROPE----[1] 193 💬
295OMS00620646, OMS620646, MASP-2 Antibody----[1] 109 💬
296OMS643762----[1] 8 💬
297OMS721----[3] 64, 66, 109 💬
298OMS721 (narsoplimab)[1] Narsoplimab[1] Narsoplimab 💬 [1] MASP2 💬 [3] Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬[3] 66, 222, 223 💬
299OMS721 100 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody----[2] 64, 109 💬
300OMS721 185 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody----[2] 64, 109 💬
301OMS721 Drug Product 185 mg/mL----[1] 109 💬
302OMS906[1] OMS906---[2] 62, 223 💬
303OMS906 study drug[1] OMS906---[2] 62, 223 💬
304OMT-28----[1] 21 💬
305ON 01910.NA----[1] 36 💬
306ON Dopaminergic Medication----[1] 6 💬
307Onabotulinum Toxin A----[1] 226 💬
308Onabotulinumtoxin A----[2] 51, 226 💬
309Onabotulinumtoxin A Injection----[1] 6 💬
310OnabotulinumtoxinA----[2] 6, 13 💬
311Onabotulinumtoxina for Injection----[1] 149 💬
312ONASEMNOGENE ABEPARVOVEC[1] Onasemnogene abeparvovec[1] Onasemnogene abeparvovec 💬 --[1] 3 💬
313Onasemnogene Abeparvovec-brve[1] Onasemnogene abeparvovec[1] Onasemnogene abeparvovec 💬 --[1] 3 💬
314Onasemnogene Abeparvovec-xioi[1] Onasemnogene abeparvovec[1] Onasemnogene abeparvovec 💬 --[1] 3 💬
315Once a day Trientine----[1] 171 💬
316Once-daily insulin detemir[1] Insulin detemir[1] Insulin detemir 💬 [1] INSR 💬 [23] AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Hormone signaling, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 299 💬
317Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter[2] Iodide,
Sodium iodide		[3] Sodium iodide ,
Sodium iodide I 123 ,
Sodium iodide I 125 💬 		--[1] 34 💬
318Oncoxin + Viusid----[1] 46 💬
319Ondansetron[1] Ondansetron[2] Ondansetron ,
Ondansetron hydrochloride hydrate 💬 		[5] HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬 		[3] Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬[5] 6, 97, 98, 107, 231 💬
320Ondansetron 8 mg film-coated tablets[1] Ondansetron[2] Ondansetron ,
Ondansetron hydrochloride hydrate 💬 		[5] HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬 		[3] Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬[1] 6 💬
321Ondansetron hydrochloride dihydrate[1] Ondansetron[2] Ondansetron ,
Ondansetron hydrochloride hydrate 💬 		[5] HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬 		[3] Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬[2] 6, 97 💬
322One additional blood sample during a planned blood test----[1] 266 💬
323One Alpha Drops----[2] 50, 107 💬
324One ml contains horse anti-human T lymphocyte immunoglobulin (eATG) 50 mg----[1] 60 💬
325One-Alpha drops----[2] 50, 107 💬
326Ongentys----[1] 6 💬
327Ongentys 50 mg capsule rigide----[1] 6 💬
328Ongentys 50 mg hard capsules----[1] 6 💬
329Ongentys 50mg----[1] 6 💬
330Ongentys®----[1] 6 💬
331Ongericimab[1] Ongericimab---[1] 79 💬
332Only 1 arm: treatment with MSC-AFP----[1] 96 💬
333ONO-1110----[1] 226 💬
334ONO-2506----[1] 2 💬
335ONO-2506PO----[2] 2, 6 💬
336ONO-2808----[1] 17 💬
337ONO-4059----[1] 35 💬
338ONO-4641----[1] 13 💬
339ONO-4641/ MSC2430913A----[1] 13 💬
340ONO-4641/MSC2430913A----[1] 13 💬
341ONO-5788----[1] 77 💬
342Onpattro----[1] 28 💬
343ONT01 is a small molecule CD11b modulator.----[1] 49 💬
344Ontamalimab[1] Ontamalimab---[2] 96, 97 💬
345Opana----[1] 70 💬
346OPC----[1] 6 💬
347OPC-41061----[1] 67 💬
348OPC-6535----[2] 96, 97 💬
349OPC-6535 Tablets (drug)----[1] 97 💬
350OPC-6535(Tetomilast)[1] Tetomilast---[2] 96, 97 💬
351OpCT-001----[3] 90, 301, 303 💬
352Open Label (Avatrombopag tablets)[1] Avatrombopag[2] Avatrombopag ,
Avatrombopag maleate 💬 		[1] MPL 💬 [3] Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬[1] 63 💬
353Open label - AL001----[1] 127 💬
354Open Label Clemastine with a blinded randomize withdrawal[1] Clemastine[2] Clemastine fumarate ,
Clemastine 💬 		[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 179 💬
355Open label Namilumab[1] Namilumab---[1] 84 💬
356Open label RAD001 (only used for post-extension phase)----[1] 158 💬
357Open Label Topical Beremagene Geperpavec (B-VEC)[1] Beremagene geperpavec[1] Beremagene geperpavec 💬 [1] COL7A1 💬 [2] Cornified envelope formation, Protein digestion and absorption 💬[1] 36 💬
358Open-Label----[1] 97 💬
359Open-label Abatacept[1] Abatacept[1] Abatacept 💬 [2] CD80,
CD86 💬 		[14] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬[1] 46 💬
360Open-label Adalimumab[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
361Open-Label CDCA 250 mg TID----[1] 263 💬
362Open-label PTH(1-84)----[1] 235 💬
363Open-labelAdalimumabRescue----[1] 46 💬
364Operative Cystoscopy----[1] 226 💬
365Ophthalmic Emulsion----[2] 51, 53 💬
366Ophthalmological exam----[1] 6 💬
367Ophthalmology exam----[1] 19 💬
368OPICAPONE[1] Opicapone[1] Opicapone 💬 [1] COMT 💬 [3] Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬[1] 6 💬
369Opicapone (OPC)[1] Opicapone[1] Opicapone 💬 [1] COMT 💬 [3] Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬[1] 6 💬
370Opicapone 50 mg[1] Opicapone[1] Opicapone 💬 [1] COMT 💬 [3] Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬[1] 6 💬
371Opicapone 50 mg hard capsules[1] Opicapone[1] Opicapone 💬 [1] COMT 💬 [3] Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬[1] 6 💬
372Opicinumab[1] Opicinumab[1] Opicinumab 💬 --[1] 13 💬
373Opioid based Anesthesia----[1] 70 💬
374Opioid-free Anesthesia----[1] 70 💬
375OPL-CCL2-LPM----[1] 66 💬
376OPRX-106----[1] 97 💬
377OPRX-106 (plant cells expressing TNFR-Fc) 2mg----[1] 97 💬
378OPRX-106 (plant cells expressing TNFR-Fc) 8mg----[1] 97 💬
379OPS-2071----[1] 96 💬
380OPS-2071 150 mg----[1] 96 💬
381OPS-2071 300 mg----[1] 96 💬
382OPS-2071 600 mg----[1] 96 💬
383Opsumit----[2] 86, 88 💬
384Opsumit (macitentan)[1] Macitentan[1] Macitentan 💬 [2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
385Opsumit 10 Mg Tablet----[1] 51 💬
386Opsumit®----[3] 86, 88, 210 💬
387Opsumit®Product Name: Macitentan tablets Product Code: JNJ-67896062 / ACT-064992Pharmaceutical Form: Film-coated tabletINN or Proposed INN: MACITENTANCAS Number: 441798-33-0Current Sponsor code: JNJ-67896062-AAAOther descriptive name: ACT-064992Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 10-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral useProduct Name: Macitentan tabletsProduct Code: JNJ-67896062 / ACT-064992Pharmaceutical Form: Film-coated tabletINN or Proposed INN: MACITENTANCAS Number: 441798-33-0Current Sponsor code: JNJ-67896062-AAAOther descriptive name: ACT-064992Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral useProduct Name: Macitentan tabletsProduct Code: JNJ-67896062 / ACT-064992Pharmaceutical Form: Film-coated tabletINN or Proposed INN: MACITENTANCAS Number: 441798-33-0Current Sponsor code: JNJ-67896062-AAAOther descriptive name: ACT-064992Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 37.5-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use[1] Macitentan[1] Macitentan 💬 [2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 86, 88 💬
388Opsumit®Product Name: macitentan tabletsProduct Code: JNJ-67896062 / ACT-064992Pharmaceutical Form: Film-coated tabletINN or Proposed INN: MACITENTANCAS Number: 441798-33-0Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 10-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral useProduct Name: macitentan tabletsProduct Code: JNJ-67896062 / ACT-064992Pharmaceutical Form: Film-coated tabletINN or Proposed INN: MACITENTANCAS Number: 441798-33-0Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral useProduct Name: macitentan tabletsProduct Code: JNJ-67896062 / ACT-064992Pharmaceutical Form: Film-coated tabletINN or Proposed INN: MACITENTANCAS Number: 441798-33-0Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 37.5-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use[1] Macitentan[1] Macitentan 💬 [2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
389Optimal drug therapy----[1] 6 💬
390Optimal therapy for cardiaca failure----[1] 57 💬
391Optimized antiparkinsonian treatment----[1] 6 💬
392Optimized Medical Treatment----[1] 6 💬
393Optimized oral treatment----[1] 6 💬
394Optimized Prophylactic IM Therapy----[1] 19 💬
395Optimized Treatment (OPT)----[2] 96, 97 💬
396Optinate 5 mg filmcoated tablets----[1] 274 💬
397Optional Bronchoscopy----[1] 85 💬
398Optional collection----[3] 46, 49, 51 💬
399Optional lumbar puncture + blood sample----[1] 138 💬
400Optional Prednisone[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 127 💬
401Optional Sirolimus[1] Sirolimus[1] Sirolimus 💬 [1] MTOR 💬 [52] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 127 💬
402Optison----[1] 96 💬
403Oral----[3] 46, 57, 271 💬
404Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
405Oral administration of 100 mg KH176 twice daily----[1] 21 💬
406Oral all-trans retinoic acid (ATRA)----[1] 94 💬
407Oral anti-Parkinson drugs and injection of botulinum toxin----[1] 6 💬
408Oral anti-Parkinson's drugs----[1] 6 💬
409Oral anticoagulant treatment----[1] 86 💬
410Oral Aztreonam[1] Aztreonam[2] Aztreonam ,
Aztreonam lysine 💬 		--[1] 299 💬
411Oral bovine type I collagen[1] Bovine type I collagen---[1] 51 💬
412Oral bovine type II collagen----[1] 46 💬
413Oral Brepocitinib[1] Brepocitinib[1] Brepocitinib 💬 [2] JAK1,
TYK2 💬 		[27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 84 💬
414Oral Budesonide[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 97, 98 💬
415Oral Budesonide Suspension (MB-9)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
416Oral Budesonide Suspension (OBS)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
417Oral capsule-delivered FMT----[1] 6 💬
418Oral cholera vaccine----[1] 97 💬
419Oral ciprofloxacin[1] Ciprofloxacin[3] Ciprofloxacin ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate 💬 		--[1] 299 💬
420Oral ciprofloxacin plus inhaled colistin[2] Ciprofloxacin,
Colistin		[5] Ciprofloxacin ,
Colistin sulfate ,
Ciprofloxacin hydrochloride ,
Ciprofloxacin lactate ,
Colistin 💬 		--[1] 299 💬
421Oral contrast media application----[1] 96 💬
422Oral Corticosteroid Tapering Schedule----[1] 11 💬
423Oral corticosteroids----[4] 13, 46, 97, 251 💬
424Oral corticosteroids (OCS)----[1] 162 💬
425Oral cromolyn sodium----[1] 98 💬
426Oral Cyclosporine[1] Cyclosporine[1] Cyclosporine 💬 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[2] 222, 223 💬
427Oral disulfiram[1] Disulfiram[1] Disulfiram 💬 [3] ALDH1B1,
ALDH2,
ALDH3A2 💬 		[13] Alcoholic liver disease, Arginine and proline metabolism, Ascorbate and aldarate metabolism, Fatty acid degradation, Glycerolipid metabolism, Glycolysis / Gluconeogenesis, Histidine metabolism, Lysine degradation, Pantothenate and CoA biosynthesis, Pyruvate metabolism, Tryptophan metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[2] 90, 301 💬
428Oral drops solution----[1] 28 💬
429Oral ERA----[1] 86 💬
430Oral erythromycin[1] Erythromycin[7] Erythromycin ,
Erythromycin estolate ,
Erythromycin ethylsuccinate ,
Erythromycin lactobionate ,
Erythromycin stearate ,
Erythromycin gluceptate ,
Erythromycin thiocyanate 💬 		--[1] 36 💬
431Oral escitalopram[1] Escitalopram[2] Escitalopram oxalate ,
Escitalopram 💬 		[1] SLC6A4 💬 [3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 6 💬
432Oral ferrous sulfate[1] Ferrous sulfate anhydrous[1] Ferrous sulfate 💬 --[1] 97 💬
433Oral Glucocorticoids----[1] 13 💬
434Oral Glucose Tolerance Test----[1] 299 💬
435Oral Glucose Tolerance test (75g 2-hour)----[1] 299 💬
436Oral Glutathione[1] Glutathione[1] Glutathione 💬 --[1] 299 💬
437Oral Ifetroban[1] Ifetroban[2] Ifetroban ,
Ifetroban sodium 💬 		[1] TBXA2R 💬 [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬[2] 51, 86 💬
438Oral immunosuppressant----[1] 13 💬
439Oral IR-LD/CD----[1] 6 💬
440Oral Iron[1] Iron[1] Ferrous fumarate 💬 --[2] 97, 254 💬
441Oral Levodopa/Carbidopa[2] Carbidopa,
Levodopa		[2] Levodopa ,
Carbidopa 💬 		[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6 💬
442Oral LEVOSIMENDAN[1] Levosimendan[1] Levosimendan 💬 [2] PDE3A,
PDE3B 💬 		[10] Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2 💬
443Oral lipoic acid (LA)[1] Lipoic acid[1] Thioctic acid 💬 --[1] 13 💬
444Oral liposomal iron----[1] 97 💬
445Oral methotrexate[1] Methotrexate[2] Methotrexate ,
Methotrexate sodium 💬 		[2] DHFR,
DHFR2 💬 		[3] Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬[1] 46 💬
446Oral Methylprednisolone 625 mg/24h x3 days[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
447Oral migalastat HCl[1] Migalastat[2] Migalastat hydrochloride ,
Migalastat 💬 		[1] GLA 💬 [5] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬[1] 19 💬
448Oral nutritional supplementation----[1] 2 💬
449Oral OKT3----[1] 97 💬
450Oral PDE5 inhibitors----[1] 86 💬
451Oral Pednisolone----[1] 145 💬
452Oral prednisolone[1] Prednisolone[1] Prednisolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 49, 96, 145 💬
453Oral prednisolone and cyclophosphamide[2] Cyclophosphamide,
Prednisolone		[3] Cyclophosphamide ,
Prednisolone ,
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
454Oral prednisolone and SoC[1] Prednisolone[1] Prednisolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
455Oral prednisolone Taper[1] Prednisolone[1] Prednisolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
456Oral Prednisone[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
457Oral Prednisone - Hospital Dose Steroids[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
458Oral Prednisone 5mg[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
459Oral probiotic----[1] 291 💬
460Oral reduced l-glutathione[1] Glutathione[1] Glutathione 💬 --[1] 299 💬
461Oral roflumilast[1] Roflumilast[1] Roflumilast 💬 [4] PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 		[4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 299 💬
462Oral SCIO-469 capsule----[1] 46 💬
463Oral selexipag (Uptravi)[1] Selexipag[1] Selexipag 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
464Oral sildenafil[1] Sildenafil[2] Sildenafil citrate ,
Sildenafil 💬 		[1] PDE5A 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
465Oral sirolimus[1] Sirolimus[1] Sirolimus 💬 [1] MTOR 💬 [52] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 278 💬
466Oral THC----[1] 13 💬
467Oral treprostinil[1] Treprostinil[3] Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[2] 51, 86 💬
468Oral treprostinil (UT-15C) Sustained Release Tablets[1] Treprostinil[3] Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
469Oral Upadacitinib[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 97 💬
470Oral Vancomycin[1] Vancomycin[2] Vancomycin ,
Vancomycin hydrochloride 💬 		--[3] 94, 97, 296 💬
471Oral vancomycin and oral amoxicillin[2] Amoxicillin,
Vancomycin		[5] Vancomycin ,
Amoxicillin ,
Vancomycin hydrochloride ,
Amoxicillin sodium ,
Amoxicillin 💬 		--[1] 94 💬
472Oral Viscous Budesonide[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
473Oral Viscous Budesonide (OVB)[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
474Oral zamicastat[1] Zamicastat---[1] 86 💬
475Orally disintegrating selegiline (Zelapar)[1] Selegiline[2] Selegiline hydrochloride ,
Selegiline 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
476OraPlus----[1] 310 💬
477Orbcel-C----[2] 94, 95 💬
478Orca-Q----[1] 13 💬
479Order of two elements of surgical procedure----[1] 51 💬
480Ordinary meat diet----[1] 97 💬
481ORE1001----[1] 97 💬
482Orelabrutinib[1] Orelabrutinib[1] Orelabrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[5] 13, 49, 53, 61, 63 💬
483Orelabrutinib (High Dose)[1] Orelabrutinib[1] Orelabrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 49 💬
484Orelabrutinib (Low Dose)[1] Orelabrutinib[1] Orelabrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 49 💬
485Orelabrutinib( higher dose)[1] Orelabrutinib[1] Orelabrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 63 💬
486Orelabrutinib( lower dose)[1] Orelabrutinib[1] Orelabrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 63 💬
487Orelabrutinib-100[1] Orelabrutinib[1] Orelabrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 61 💬
488Orelabrutinib-150[1] Orelabrutinib[1] Orelabrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 61 💬
489Orelabrutinib-50[1] Orelabrutinib[1] Orelabrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 61 💬
490ORENCIA----[16] 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 223, 271, 300 💬
491Orencia (abatacept)[1] Abatacept[1] Abatacept 💬 [2] CD80,
CD86 💬 		[14] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬[1] 46 💬
492Orencia (trade name)----[1] 50 💬
493Orencia 125 mg----[1] 46 💬
494Orencia 125 mg Injektionslösung im Fertigpen----[1] 46 💬
495ORENCIA 125 mg solution for injection----[1] 46 💬
496ORENCIA 125 mg solution for injection in pre-filled syringe----[3] 46, 49, 53 💬
497ORENCIA 125 mg, solution injectable en seringue préremplie----[1] 46 💬
498ORENCIA 250 mg polvo para concentrado para sol. para perfusión----[1] 46 💬
499ORENCIA 250mg powder for concentrate for solution for infusion----[1] 46 💬
500Orencia abatacept[1] Abatacept[1] Abatacept 💬 [2] CD80,
CD86 💬 		[14] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬[1] 46 💬
501Orencia Injektionslösung in einer Fertigspritze----[1] 46 💬
502ORENCIA Subcutaneous Injection----[1] 46 💬
503ORENCIA*IV 2FL 250MG+2SIR----[1] 46 💬
504Orencia® (Abatacept)[1] Abatacept[1] Abatacept 💬 [2] CD80,
CD86 💬 		[14] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬[1] 95 💬
505ORENCIA® 125 mg solution for injection in pre-filled syringe----[1] 65 💬
506Orfadin----[2] 6, 241 💬
507Orfadin oral suspension 4mg/ml----[1] 241 💬
508Orfiril Saft----[1] 3 💬
509Originator----[2] 46, 271 💬
510Originator (legacy) drug----[4] 46, 96, 97, 271 💬
511Originator adalimumab[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 107 💬
512Originator rituximab - Rituxan ® or MabThera ®[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
513ORILANOLIMAB[1] Orilanolimab[1] Orilanolimab 💬 --[1] 61 💬
514ORIN1001----[1] 85 💬
515Orkambi----[1] 299 💬
516Orkambi 100 mg/125 mg film-coated tablets----[1] 299 💬
517Orkambi 200 mg/125 mg film-coated tablets----[1] 299 💬
518Orkambi: contains lumacaftor and ivacaftor[2] Ivacaftor,
Lumacaftor		[2] Ivacaftor ,
Lumacaftor 💬 		[1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
519Orkambi®----[1] 299 💬
520ORL-1B----[1] 255 💬
521Orladeyo----[1] 65 💬
522ORM-12471----[1] 51 💬
523ORM-12471 30mg----[1] 51 💬
524ORM-12741[1] ORM-12741---[1] 51 💬
525ORMONE PARATIROIDEO DA DNA RICOMBINANTE----[1] 235 💬
526Orncia----[1] 46 💬
527Ornithine[1] Ornithine[2] Ornithine ,
Ornithine aspartate 💬 		--[3] 96, 245, 251 💬
528Ornithine alpha ketoglutarate[1] Ornithine[2] Ornithine ,
Ornithine aspartate 💬 		--[1] 245 💬
529OROCAL----[1] 75 💬
530ORT247----[1] 2 💬
531Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg[2] Estradiol,
Norgestimate		[3] Estradiol ,
Norgestimate ,
Estradiol hemihydrate 💬 		[3] ESR1,
ESR2,
PGR 💬 		[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 299 💬
532Ortho-Novum 777----[1] 49 💬
533Ortho-Novum® 1/35----[1] 46 💬
534ORVEPITANT[1] Orvepitant[1] Orvepitant 💬 [1] TACR1 💬 [3] Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 85 💬
535Orvepitant Maleate[1] Orvepitant[1] Orvepitant 💬 [1] TACR1 💬 [3] Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 85 💬
536ORY2001----[1] 13 💬
537OS440----[1] 13 💬
538OSCN-----[1] 299 💬
539OSE-127----[2] 53, 97 💬
540Oseltamivir[1] Oseltamivir[2] Oseltamivir phosphate ,
Oseltamivir 💬 		--[3] 63, 97, 299 💬
541OSILODROSTAT[1] Osilodrostat[2] Osilodrostat ,
Osilodrostat phosphate 💬 		[1] CYP11B2 💬 [2] Aldosterone synthesis and secretion, Steroid hormone biosynthesis 💬[1] 75 💬
542Osilodrostat 10mg[1] Osilodrostat[2] Osilodrostat ,
Osilodrostat phosphate 💬 		[1] CYP11B2 💬 [2] Aldosterone synthesis and secretion, Steroid hormone biosynthesis 💬[1] 75 💬
543Osilodrostat 1mg[1] Osilodrostat[2] Osilodrostat ,
Osilodrostat phosphate 💬 		[1] CYP11B2 💬 [2] Aldosterone synthesis and secretion, Steroid hormone biosynthesis 💬[1] 75 💬
544Osilodrostat 20mg[1] Osilodrostat[2] Osilodrostat ,
Osilodrostat phosphate 💬 		[1] CYP11B2 💬 [2] Aldosterone synthesis and secretion, Steroid hormone biosynthesis 💬[1] 75 💬
545Osilodrostat 5mg[1] Osilodrostat[2] Osilodrostat ,
Osilodrostat phosphate 💬 		[1] CYP11B2 💬 [2] Aldosterone synthesis and secretion, Steroid hormone biosynthesis 💬[1] 75 💬
546Osilodrostat and cabergoline[2] Cabergoline,
Osilodrostat		[3] Cabergoline ,
Osilodrostat ,
Osilodrostat phosphate 💬 		[3] CYP11B2,
DRD2,
PRL 💬 		[16] Alcoholism, Aldosterone synthesis and secretion, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, Steroid hormone biosynthesis, cAMP signaling pathway 💬[1] 75 💬
547OSOME----[1] 19 💬
548OsrhAAT 1 mg/kg IV----[1] 231 💬
549OsrhAAT 10 mg/kg IV----[1] 231 💬
550OsrhAAT 20 mg/kg IV----[1] 231 💬
551OsrhAAT 3 mg/kg IV----[1] 231 💬
552OsrhAAT 40 mg/kg IV----[1] 231 💬
553OsrhAAT 60 mg/kg IV----[1] 231 💬
554Ossein hydroxyapatite----[1] 75 💬
555OSSIDO DI AZOTO----[1] 294 💬
556Ossido Nitrico----[1] 86 💬
557OSSITOCINA----[2] 127, 193 💬
558Ossium vBM-MSC----[1] 96 💬
559OSSM-001----[1] 96 💬
560OST-122----[1] 97 💬
561Osteoblast biology study----[1] 238 💬
562Osteomalacia----[1] 238 💬
563Osteopetrosis Haploidentical Only Preparative Regimen----[5] 19, 20, 125, 234, 326 💬
564Osteopetrosis Only Preparative Regimen----[5] 19, 20, 125, 234, 326 💬
565OSTEOPOR----[1] 75 💬
566OSU 6162----[2] 6, 8 💬
567OSU 6162 similar to (-)-OSU 6162----[1] 6 💬
568OSU6162----[2] 6, 8 💬
569OSU6162 similar to (-)-OSU 6162----[2] 6, 8 💬
570OT----[1] 193 💬
571Otelixizumab[1] Otelixizumab[1] Otelixizumab 💬 [3] CD3D,
CD3E,
CD3G 💬 		[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 46 💬
572Otezla----[3] 56, 107, 162 💬
573OTEZLA - 10 MG + 20 MG + 30 MG COMPRESSA RIVESTITA CON FILM USO ORALE - BLISTER (PVC/ALU) IN UN ASTUCCIO - 4 COMPRESSE DA 10 MG + 4 COMPRESSE DA 20 MG +19 COMPRESSE DA 30 MG----[2] 56, 107 💬
574OTEZLA - 30 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PVC/ALU) - 56 COMPRESSE----[1] 107 💬
575Other analgesics and antipyretics----[1] 13 💬
576Other antiepileptics----[1] 140 💬
577Other Biologic Therapies----[2] 96, 97 💬
578Other biological agent----[2] 46, 96 💬
579Other Biologics----[1] 46 💬
580Other COX-2 inhibitor----[1] 271 💬
581Other Cox-2 inhibitors----[1] 271 💬
582Other Crystalloid----[1] 296 💬
583Other disease-modifying therapy----[1] 13 💬
584Other DMARDs----[1] 46 💬
585Other H1 antagonist----[1] 13 💬
586Other hematological Agents----[1] 65 💬
587Other intervention(s)----[1] 70 💬
588OTHER NERVOUS SYSTEM DRUGS----[2] 6, 13 💬
589Other Non Steroidal Anti-Inflammatory Drugs (NSAIDs) except etodolac[1] Etodolac[1] Etodolac 💬 [1] PTGS2 💬 [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46 💬
590Other Non-selective NSAIDs----[1] 271 💬
591Other non-sponsor pancreatic enzyme replacement therapy----[1] 299 💬
592Other Parkinson's Disease treatments----[1] 6 💬
593Other respiratory system products----[1] 299 💬
594OTHER SOURCES----[1] 228 💬
595Other treatment----[1] 13 💬
596Other vasodilator----[1] 51 💬
597Other:----[3] 2, 6, 65 💬
598Other: 0.02% Fm, SH, tBCL----[1] 53 💬
599Other: 0.9% sodium chloride[1] Sodium chloride[1] Sodium chloride 💬 --[1] 65 💬
600Other: 0.9ml sodium chloride[1] Sodium chloride[1] Sodium chloride 💬 --[1] 271 💬
601Other: 1 blood sample----[1] 299 💬
602Other: 1 blood sample, 40 mL (collection during a blood test, part of the standard of care for this disease)----[1] 53 💬
603Other: 1 Food Elimination Diet----[1] 98 💬
604Other: 1 Food Elimination Diet Therapy----[1] 98 💬
605Other: 100% pomegranate juice[1] Pomegranate---[2] 96, 97 💬
606Other: 12-month Questionnaire----[1] 299 💬
607Other: 13C6 Leucine[1] Leucine[1] Leucine 💬 --[3] 5, 7, 127 💬
608Other: 18F-FDG----[2] 46, 84 💬
609Other: 18F-FDG PET/CT----[1] 41 💬
610Other: 18F-Fluorodeoxyglucose (18F-FDG) PET/CT----[1] 84 💬
611Other: 18F-GE-180----[1] 46 💬
612Other: 1H/31P Magnetic Resonance Spectroscopy----[1] 77 💬
613Other: 2 blood samples----[1] 299 💬
614Other: 20 ml venous blood collection----[1] 168 💬
615Other: 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.----[1] 49 💬
616Other: 24 hours sampling of 4 biological fluids (blood, ISF, sweat and saliva)----[1] 75 💬
617Other: 24 hours sampling of ISF or sweat (after validating the correlation with blood)----[1] 75 💬
618Other: 31-Phosphorus RMN Spectroscopy[1] Phosphorus---[1] 8 💬
619Other: 4 Food Elimination Diet----[1] 98 💬
620Other: 4 Food Elimination Diet (post 1FED failure)----[1] 98 💬
621Other: 5-ASA Withdrawal----[1] 96 💬
622Other: 6 Food Elimination Diet (after 1FED failure)----[1] 98 💬
623Other: 6 Food Elimination Diet Therapy----[1] 98 💬
624Other: 6-minute walk distance (6MWD) test----[2] 86, 88 💬
625Other: 6-minute walk distance (6MWD) test on ambient air----[2] 86, 88 💬
626Other: 6-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)[1] Oxygen[1] Oxygen 💬 --[2] 86, 88 💬
627Other: 6-minute walk distance test with supplemental oxygen[1] Oxygen[1] Oxygen 💬 --[2] 86, 88 💬
628Other: 6-minute walk test----[1] 113 💬
629Other: 60% Oxygen[1] Oxygen[1] Oxygen 💬 --[1] 85 💬
630Other: 9-hole test----[1] 113 💬
631Other: [11C]-Methionine PET/MRI[1] Methionine[1] Methionine 💬 --[1] 75 💬
632Other: [11C]donepezil PET[1] Donepezil[2] Donepezil hydrochloride ,
Donepezil 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
633Other: A plant based high fiber diet that mimics fasting (FMD) plus advanced therapy----[1] 97 💬
634Other: A sampling of blood----[1] 299 💬
635Other: A-STEP----[1] 299 💬
636Other: A-STEP (New Protocol)----[1] 299 💬
637Other: Abdominal compression----[1] 17 💬
638Other: Absorptive clearance scan----[1] 299 💬
639Other: Acetaminophen[1] Acetaminophen[1] Acetaminophen 💬 [2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 96 💬
640Other: Active Comparator----[2] 43, 44 💬
641Other: Acupuncture----[1] 70 💬
642Other: Acupuncture combined with oral hydroxychloroquine sulfate tablets[1] Hydroxychloroquine[2] Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--[1] 53 💬
643Other: acupuncture GB20 or GB20 plus BL2----[1] 53 💬
644Other: Ad libitum water intake[1] Water[1] Water 💬 --[1] 67 💬
645Other: Adalimumab[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
646Other: Adalimumab treatment[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 151 💬
647Other: Additional Therapies----[1] 97 💬
648Other: Advanced therapy----[2] 96, 97 💬
649Other: Aerobic exercises----[1] 49 💬
650Other: Aerobic training----[1] 13 💬
651Other: AIDAI score----[1] 106 💬
652Other: Air - oxygen[1] Oxygen[1] Oxygen 💬 --[1] 299 💬
653Other: Alcohol intake----[1] 46 💬
654Other: All patients will receive CD19 CAR-T cell therapy on the basis of standard symptomatic and supportive treatment.----[1] 222 💬
655Other: Allogeneic hematopoietic stem cell transplantation----[1] 60 💬
656Other: ALS Functional rating Scale-revised (ALS FRS-R)----[1] 2 💬
657Other: ALS patients epidemiological caracterization----[1] 2 💬
658Other: amino acid mixture beverage----[1] 97 💬
659Other: Aminoacid, alanine-infusion[1] Alanine[1] Alanine 💬 --[1] 251 💬
660Other: Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised----[1] 2 💬
661Other: analysis of blood samples----[1] 13 💬
662Other: Anthropometry----[1] 15 💬
663Other: Anti inflammatory diet----[1] 97 💬
664Other: anti-CD19 CAR-T cells[1] Anti-CD19 CAR-T cells---[1] 51 💬
665Other: Anti-Inflammatory Diet----[1] 97 💬
666Other: Antigen (wheat base soy sauce) spray[1] Wheat[1] Wheat 💬 --[1] 98 💬
667Other: Antral follicle count (AFC)----[1] 13 💬
668Other: anxiety----[1] 13 💬
669Other: Anxiety/Depression Questionnaires----[1] 97 💬
670Other: Arm B- Standard of Care----[1] 97 💬
671Other: Assessment of activity and muscle fatigue----[1] 3 💬
672Other: Assessment of bulbar function----[1] 3 💬
673Other: Assessment of medication compliance----[1] 98 💬
674Other: Assessment of Psychophysiological factors----[1] 97 💬
675Other: At-home natalizumab treated MS patient[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
676Other: Autogenic drainage----[1] 299 💬
677Other: Autologous hematopoietic stem cell transplantation----[1] 13 💬
678Other: Autologous peripheral blood differentiated adult tolerogenic dendritic cells expanded----[1] 13 💬
679Other: autologous peripheral blood mononuclear cells----[1] 47 💬
680Other: Autologous Platelet rich plasma[1] Platelet Rich Plasma---[1] 35 💬
681Other: Autologous Platelet-poor Plasma (PPP) and Thrombin Coagulum Treatment[1] Thrombin[1] Thrombin 💬 --[1] 97 💬
682Other: Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum Treatment[1] Thrombin[1] Thrombin 💬 --[1] 97 💬
683Other: autologous purified CD34+ cells----[1] 47 💬
684Other: Autologous serum----[1] 53 💬
685Other: autologous serum and rebamipide 2%[1] Rebamipide[1] Rebamipide 💬 --[1] 53 💬
686Other: Balance----[3] 6, 13, 299 💬
687Other: Balance and Coordination----[1] 121 💬
688Other: Balance and strengthening exercises----[1] 6 💬
689Other: balance based torso weighting----[1] 13 💬
690Other: Balance exercise----[2] 6, 149 💬
691Other: Balance exercise program using exoskeleton device----[1] 13 💬
692Other: Balance Exercises----[1] 13 💬
693Other: Balance Exercises with Stroboscopic Glasses----[1] 13 💬
694Other: Balance exercises with Virtual Reality Glasses----[1] 13 💬
695Other: Balance Exercises with Visual-Based Metaphor Training----[1] 13 💬
696Other: Balance measurement----[1] 113 💬
697Other: Balance Tele-Rehabilitation Agility Boot Camp (ABC)----[1] 6 💬
698Other: Balance Trainer Balance Exercises----[1] 13 💬
699Other: Balance Training----[2] 6, 13 💬
700Other: Balance training only----[1] 13 💬
701Other: Balance training wiith combined neuromodulation (TSCS+FES)----[1] 13 💬
702Other: Balance training with FES----[1] 13 💬
703Other: balance-focus exercise programe----[1] 6 💬
704Other: Baseline serum vitamin D level at or above 50 nmol/l[1] Vitamin D---[1] 46 💬
705Other: Baseline serum vitamin D level below 50 nmol/l[1] Vitamin D---[1] 46 💬
706Other: beetroot juice extract----[1] 113 💬
707Other: Behavioural Monitoring----[1] 15 💬
708Other: Berg Balance Scale----[3] 6, 13, 149 💬
709Other: Berg Balance Scale (BBS)----[1] 10 💬
710Other: Best medical therapy----[1] 58 💬
711Other: Best Medical Treatment----[1] 6 💬
712Other: Best Practice----[1] 60 💬
713Other: Bilateral digital xray of hands----[1] 46 💬
714Other: Biodex balance system----[1] 6 💬
715Other: Biological analysis----[1] 265 💬
716Other: Biological samples----[1] 206 💬
717Other: Biopsies----[1] 96 💬
718Other: Biopsies, stool and blood collection----[1] 96 💬
719Other: Biopsy----[2] 51, 160 💬
720Other: Biopsy and blood sampling----[1] 96 💬
721Other: Biopsy samples----[1] 98 💬
722Other: Blood analysis for frataxin's level measurement----[1] 18 💬
723Other: Blood and placenta specimen collection.----[2] 118, 294 💬
724Other: Blood and stool sample----[2] 96, 97 💬
725Other: Blood and urine collection----[1] 97 💬
726Other: blood cardioplegia----[1] 215 💬
727Other: Blood collecting for storage of samples----[1] 107 💬
728Other: Blood collection----[7] 15, 28, 36, 49, 66, 67, 223 💬
729Other: Blood collection for lipid profiling by LC-MS----[1] 49 💬
730Other: Blood draw----[17] 2, 6, 11, 13, 18, 39, 46, 57, 77, 84, 85, 86, 88, 96, 97, 167, 299 💬
731Other: Blood draw for future biomarker analysis----[2] 13, 63 💬
732Other: Blood draw for the laboratory assessment----[1] 6 💬
733Other: Blood drawing only Group C----[1] 49 💬
734Other: Blood draws----[2] 49, 51 💬
735Other: Blood Draws for Serum Titers----[1] 107 💬
736Other: Blood Flow Restriction----[1] 13 💬
737Other: Blood Flow Restriction Exercise----[1] 13 💬
738Other: Blood flow restriction training----[3] 6, 149, 274 💬
739Other: Blood Flow Restriction training with Oclussion Cuff.----[1] 13 💬
740Other: Blood Gas----[1] 86 💬
741Other: Blood glucose results----[1] 299 💬
742Other: Blood or buccal sample----[1] 23 💬
743Other: Blood parameters----[1] 164 💬
744Other: Blood punction----[1] 51 💬
745Other: Blood sample----[37] 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
746Other: blood sample analysis----[1] 53 💬
747Other: Blood sample analysis of patients treated as standard care----[1] 46 💬
748Other: Blood sample and cotton skin swabs[1] Cotton---[1] 162 💬
749Other: Blood Sample Collection----[5] 6, 13, 51, 57, 58 💬
750Other: Blood sample collection and an optional cerebrospinal fluid (CSF) collection----[1] 6 💬
751Other: Blood sample collection for ECFC isolation and characterization----[1] 288 💬
752Other: Blood Sample Draw----[1] 11 💬
753Other: Blood sample for analysis of plasma of organochlorine pesticides concentration----[1] 49 💬
754Other: Blood sample for cell collection----[1] 49 💬
755Other: Blood sample for dosages of cytokines (IL-17 and IL-23) and of the protease MMP-9----[1] 162 💬
756Other: Blood sample taken at a single time point----[3] 13, 46, 49 💬
757Other: Blood sample Truculture----[1] 46 💬
758Other: Blood Samples----[13] 3, 13, 46, 51, 53, 63, 85, 86, 88, 96, 98, 140, 193 💬
759Other: blood samples analysis----[1] 10 💬
760Other: Blood samples and clinical data----[1] 44 💬
761Other: blood samples collection----[1] 6 💬
762Other: Blood Samples for Biomarkers----[1] 85 💬
763Other: Blood samples for PK----[1] 13 💬
764Other: Blood samples for the study of the humoral response to SARS-CoV-2 variants and of the cellular response after vaccination against COVID-19----[1] 13 💬
765Other: Blood sampling----[14] 6, 13, 19, 46, 49, 51, 53, 58, 67, 127, 222, 266, 296, 299 💬
766Other: Blood sampling (controls)----[1] 13 💬
767Other: Blood sampling (MS)----[1] 13 💬
768Other: Blood sampling and biopsy----[1] 96 💬
769Other: Blood sampling and others interventions----[1] 46 💬
770Other: Blood sampling and skin biopsy----[1] 51 💬
771Other: Blood sampling and storage for genetic analysis----[1] 84 💬
772Other: Blood sampling and storage of plasma for metabolomic analysis----[1] 84 💬
773Other: Blood sampling and urine analysis----[1] 109 💬
774Other: Blood sampling for biomarker analysis----[1] 3 💬
775Other: Blood sampling for cholestanol analysis----[1] 263 💬
776Other: Blood sampling for Laboratory Developed Test (LDT) analysis----[1] 65 💬
777Other: Blood sampling to include Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA)----[1] 49 💬
778Other: blood specimen----[4] 43, 96, 97, 329 💬
779Other: Blood test----[11] 10, 19, 46, 51, 57, 65, 66, 83, 86, 96, 113 💬
780Other: Blood Test 1----[1] 13 💬
781Other: Blood Test 2----[1] 13 💬
782Other: Blood tests----[1] 13 💬
783Other: Blood tests, intestinal biopsies, stool samples, environmental exposure questionnaire and FFQ questionnaire----[1] 96 💬
784Other: Blood withdrawal----[1] 13 💬
785Other: Blood, fecal, saliva----[1] 97 💬
786Other: Blood, fluid, sells and urine samples----[1] 53 💬
787Other: Blood-flow restricted training----[1] 15 💬
788Other: BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study.----[1] 230 💬
789Other: BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study.----[1] 230 💬
790Other: Body Composition----[2] 46, 67 💬
791Other: Bone marrow and blood sampling----[1] 19 💬
792Other: Bone Marrow aspiration----[1] 2 💬
793Other: Bone Marrow Cell Transplantation----[1] 274 💬
794Other: bone marrow collection----[1] 28 💬
795Other: both injection sclerotherapy and sirolimus[1] Sirolimus[1] Sirolimus 💬 [1] MTOR 💬 [52] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 278 💬
796Other: Brain MPET----[1] 6 💬
797Other: Brain MRI----[2] 13, 127 💬
798Other: Brain MRI (magnetic resonance imaging)----[1] 17 💬
799Other: Brain MRI with resting state scan----[1] 6 💬
800Other: Breath Analysis----[1] 84 💬
801Other: Breath Condensate Collector----[1] 86 💬
802Other: Breath Sample Collection----[1] 6 💬
803Other: Breathing exercises----[1] 6 💬
804Other: Brief Pain Inventory questionnaire----[1] 19 💬
805Other: Brief Resilient Coping Scale----[1] 46 💬
806Other: Bronchoalveolar lavage----[1] 84 💬
807Other: Bronchoalveolar samples----[1] 51 💬
808Other: BSC----[1] 85 💬
809Other: Cabergoline[1] Cabergoline[1] Cabergoline 💬 [2] DRD2,
PRL 💬 		[14] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 74 💬
810Other: Caffeine[1] Caffeine[2] Caffeine ,
Caffeine citrate 💬 		[11] ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬 		[22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
811Other: Calcium stable isotope[1] Calcium---[1] 186 💬
812Other: Calprotectin----[1] 97 💬
813Other: Capillary Blood Sampling----[1] 15 💬
814Other: carbon dioxide insufflation during colonoscopy[1] Carbon dioxide[1] Carbon dioxide 💬 --[1] 97 💬
815Other: Carbon monoxide-bubbled mediums[1] Carbon monoxide[1] Carbon monoxide 💬 --[1] 298 💬
816Other: carboxy methyl cellulose----[1] 53 💬
817Other: Cardiac evaluation----[1] 3 💬
818Other: Cardiac MRI----[1] 86 💬
819Other: Cardiac MRI with contrast----[1] 113 💬
820Other: Cardiac MRI without contrast----[1] 113 💬
821Other: Cardiopulmonary evaluation----[1] 13 💬
822Other: Cardiopulmonary exercise test----[2] 227, 280 💬
823Other: Cardiopulmonary Exercise Test (CPET)----[1] 46 💬
824Other: Cascade----[1] 79 💬
825Other: Cascade Screening----[1] 79 💬
826Other: Cascade testing----[1] 79 💬
827Other: Cawthorne Cooksey exercises----[1] 13 💬
828Other: CDPATH™----[1] 96 💬
829Other: Cellular senescence----[1] 46 💬
830Other: Cerebrospinal Fluid (CSF) sample----[1] 2 💬
831Other: Cerebrospinal fluid (CSF) sample and additional blood samples----[1] 124 💬
832Other: CF Management Questionnaire----[1] 299 💬
833Other: Challenge agent: capsaicin[1] Capsaicin[1] Capsaicin 💬 [1] TRPV1 💬 [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 19 💬
834Other: Change in glomerular filtration rate (mg/mmol) via magnetic resonance imaging (MRI) .----[1] 67 💬
835Other: Characterization, evaluation and comparison of macular pigment density----[1] 264 💬
836Other: Cheek swab----[2] 11, 13 💬
837Other: chest CT scan----[1] 65 💬
838Other: Child Sensory Profile 2 (SP2) for Sensory processing abilities----[1] 149 💬
839Other: Classic, progressive endurance training----[1] 13 💬
840Other: clinical and neurological evaluation----[1] 13 💬
841Other: Clinical and neuropsychological assessments----[1] 6 💬
842Other: Clinical assessment----[1] 13 💬
843Other: Clinical assessment and review----[1] 23 💬
844Other: Clinical data collection----[2] 49, 51 💬
845Other: Clinical evaluation----[2] 2, 10 💬
846Other: Clinical examination----[1] 46 💬
847Other: Clinical follow-up----[2] 96, 97 💬
848Other: Clinical foot evaluation----[1] 46 💬
849Other: clinical measures of disease severity and progression----[3] 5, 6, 17 💬
850Other: clinical observation----[1] 205 💬
851Other: Clinical scores----[1] 10 💬
852Other: Clinical, behavioral and cognitive evaluation----[1] 127 💬
853Other: co-transplantation of FMT and pectin[1] Pectin[1] Pectin 💬 --[1] 97 💬
854Other: Coaching Sessions----[1] 49 💬
855Other: CoDuSe balance training and step square exercises----[1] 13 💬
856Other: Coffee----[1] 96 💬
857Other: Coffee consumption----[1] 46 💬
858Other: Cognitive assessment----[1] 127 💬
859Other: Cognitive evaluation----[1] 8 💬
860Other: Cognitive Rehabilitation:----[1] 13 💬
861Other: Cognitive Training----[2] 6, 206 💬
862Other: Colchicine Cessation[1] Colchicine[1] Colchicine 💬 [9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[12] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 266 💬
863Other: colchicine only[1] Colchicine[1] Colchicine 💬 [9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[12] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 266 💬
864Other: Collect of blood, urines, and intestinal biopsies----[1] 97 💬
865Other: Collecting discarded blood samples----[1] 210 💬
866Other: Collectio nof blood----[1] 48 💬
867Other: Collection of blood samples----[2] 56, 226 💬
868Other: collection of clinical parameters and blood sample----[1] 46 💬
869Other: collection of CSF, blood, urine, saliva----[1] 6 💬
870Other: Collection of epidemiological and anamnestic data and collection of biological material (peripheral blood)----[1] 48 💬
871Other: collection of gut biopsies collection of blood samples----[2] 94, 97 💬
872Other: Collection of stool and blood samples----[1] 97 💬
873Other: Collection of umbilical cord blood----[1] 211 💬
874Other: colonoscopy----[2] 96, 97 💬
875Other: Colored water[1] Water[1] Water 💬 --[1] 97 💬
876Other: Combined Otago-Based and Game-Inspired Balance Training----[1] 13 💬
877Other: Communicative Effectiveness Survey----[1] 2 💬
878Other: Comparator: CPET cycle ergometer (Gold Standard)[1] Gold---[1] 299 💬
879Other: Complete blood count----[2] 46, 49 💬
880Other: Complete physical examination----[2] 111, 113 💬
881Other: Computer game based balance and walking rehabilitation for individuals with Parkinson's Disease----[1] 6 💬
882Other: Computer-assisted telephone interview----[1] 85 💬
883Other: Concomitant Medication----[1] 49 💬
884Other: Conservative rehabilitation----[1] 149 💬
885Other: Consultation with a cardiologist-lipidologist (correction of therapy, lifestyle, diet)----[1] 79 💬
886Other: Consultation with a psychologist in certain centers----[1] 46 💬
887Other: Continuation of dornase alfa (Dnase)[1] Dornase alfa[1] Dornase alfa 💬 --[1] 299 💬
888Other: Continuation of hypertonic saline (HS)----[1] 299 💬
889Other: continue their usual therapy----[1] 66 💬
890Other: Continuous subcutaneous apomorphine infusion (CSAI)[1] Apomorphine[2] Apomorphine hydrochloride ,
Apomorphine 💬 		[2] DRD1,
DRD2 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
891Other: Control----[12] 6, 19, 67, 70, 75, 85, 96, 97, 162, 193, 226, 296 💬
892Other: Control Diet----[2] 96, 97 💬
893Other: Control group----[3] 2, 57, 269 💬
894Other: Control group(Normal saline)----[1] 97 💬
895Other: Control wound treatment----[1] 36 💬
896Other: Controlled environment tests (series of tasks of everyday life)----[1] 6 💬
897Other: Controls----[1] 57 💬
898Other: Controls Primary Cervical Dystonia (Trihexyphenidyl)[1] Trihexyphenidyl[2] Trihexyphenidyl hydrochloride ,
Trihexyphenidyl 💬 		[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 6 💬
899Other: conventional balance training----[1] 13 💬
900Other: Conventional drugs----[1] 97 💬
901Other: Conventional physiotherapy----[1] 6 💬
902Other: Conventional Rehabilitation----[1] 149 💬
903Other: conventional therapy----[1] 6 💬
904Other: Cord-blood mesenchymal stromal cells----[1] 222 💬
905Other: Core stability----[1] 13 💬
906Other: Core Stability Training----[1] 6 💬
907Other: Core stabilization exercises----[1] 6 💬
908Other: corn starch----[1] 49 💬
909Other: corticotropin releasing hormone (CRH)[1] Corticotropin[2] Corticotropin ,
Corticotropin, repository 💬 		[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 78 💬
910Other: Cough monitor----[1] 85 💬
911Other: Covid-19 vaccine----[1] 13 💬
912Other: Crohn's disease activity index (CDAI)----[1] 96 💬
913Other: Crohn's disease exclusion diet (CDED)----[1] 96 💬
914Other: Crohns Disease Exclusion Diet----[1] 96 💬
915Other: CSF Sampling----[1] 13 💬
916Other: CSF, blood and urine sampling----[3] 5, 6, 17 💬
917Other: Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation----[1] 65 💬
918Other: Cultured Thymus Tissue Implantation with Parathyroid Transplantation----[1] 65 💬
919Other: current treatment----[1] 46 💬
920Other: cyclosporin A----[1] 60 💬
921Other: Cyclosporine[1] Cyclosporine[1] Cyclosporine 💬 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 53 💬
922Other: Cysteamine bitartrate[1] Cysteamine[3] Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--[1] 19 💬
923Other: D-xylose[1] Xylose[1] Xylose 💬 --[1] 98 💬
924Other: D5W----[1] 222 💬
925Other: Dalfampridine plus physical therapy[1] Dalfampridine[1] Dalfampridine 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
926Other: Data Capture----[1] 6 💬
927Other: data collection----[2] 13, 299 💬
928Other: Data collection for cellular analyses (Immune subset composition, GCR expression, in vitro steroid responsiveness)----[1] 41 💬
929Other: Data collection for correlation between clinical defined and lab defined GC responsivness----[1] 41 💬
930Other: Data collection for exploratory analyses of endogenous steroid hormones----[1] 41 💬
931Other: Data collection for Prednisone metabolism[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
932Other: Data-Collection----[1] 160 💬
933Other: De-implementation of Inhaled Nitric Oxide (iNO) use[1] Nitric Oxide[1] Nitric oxide 💬 --[1] 294 💬
934Other: Dead Sea Solar and Water Treatment[1] Water[1] Water 💬 --[1] 46 💬
935Other: del nido cardioplegia----[1] 215 💬
936Other: Depression, Anxiety and Stress Scale (DASS-21)----[1] 46 💬
937Other: Determination of calcium intake by a dietician interview[1] Calcium---[2] 13, 46 💬
938Other: dextrose water 5%[1] Water[1] Water 💬 --[1] 56 💬
939Other: DFPP&CTX----[1] 223 💬
940Other: diagnostic laboratory biomarker analysis----[1] 74 💬
941Other: Diagnostics for glucose tolerance with 3 different methods.----[1] 299 💬
942Other: Diary completion----[1] 6 💬
943Other: Diet----[1] 240 💬
944Other: Diet Only----[1] 240 💬
945Other: Diet questionnaire and diet diary----[1] 240 💬
946Other: Diet treatment----[1] 240 💬
947Other: Diet, various diets will be observed----[2] 2, 4 💬
948Other: dietary acrylamide exposure measured via biomarkers in blood (hemoglobin adducts of acrylamide and glycidamide)[1] Hemoglobin---[1] 6 💬
949Other: dietary intervention with no-carrageenan diet----[1] 97 💬
950Other: Dietary pattern----[1] 46 💬
951Other: Dietary patterns----[1] 46 💬
952Other: Dietary recommendations----[1] 51 💬
953Other: Digestible Maltodextrin[1] Maltodextrin[1] Maltodextrin 💬 --[1] 96 💬
954Other: Diluent----[1] 2 💬
955Other: dimethyl fumarate (DMF)[1] Dimethyl fumarate[1] Dimethyl fumarate 💬 [1] KEAP1 💬 [6] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬[1] 13 💬
956Other: diroximel fumarate (DRF)[1] Diroximel fumarate[1] Diroximel fumarate 💬 --[1] 13 💬
957Other: Disability evaluation tests----[1] 13 💬
958Other: Discontinuation of 5-ASA----[2] 96, 97 💬
959Other: Discontinuation of dornase alfa (Dnase)[1] Dornase alfa[1] Dornase alfa 💬 --[1] 299 💬
960Other: Discontinuation of hypertonic saline (HS)----[1] 299 💬
961Other: Disease Activity (DAS-28) Assessment----[1] 46 💬
962Other: DMT category 1----[1] 13 💬
963Other: DMT withdrawal----[1] 13 💬
964Other: dobutamine[1] Dobutamine[3] Dobutamine hydrochloride ,
Dobutamine ,
Dobutamine tartrate 💬 		[1] ADRB1 💬 [13] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 215 💬
965Other: Donor derived G-CSF mobilized PBC----[1] 60 💬
966Other: Dosage of Delta-aminolevulinic acid and Porphobilinogen[2] Aminolevulinic acid,
Porphobilinogen		[2] Aminolevulinic acid hydrochloride ,
Aminolevulinic acid 💬 		--[1] 254 💬
967Other: Dosage of serotonin and metabolites[1] Serotonin---[1] 164 💬
968Other: Dose reduction to 2mg/L----[1] 46 💬
969Other: Dose reduction to 5mg/L----[1] 46 💬
970Other: Drawing blood spots from Newborns----[1] 256 💬
971Other: Dried blood spot test----[1] 19 💬
972Other: Dried blood spot test for MPS----[1] 19 💬
973Other: Drug free----[1] 49 💬
974Other: Drug level blood tests----[1] 46 💬
975Other: drug therapy for ITP----[1] 63 💬
976Other: Dual Task Performance----[1] 13 💬
977Other: Dual-Task Balance and Gait Training----[1] 6 💬
978Other: Dummy Tripterygium wilfordii Hook F (TwHF)----[1] 46 💬
979Other: Dynamic Balance Training----[1] 13 💬
980Other: Dynamic balance walking training----[1] 13 💬
981Other: Dynamometry----[1] 15 💬
982Other: Dystrophin levels----[1] 113 💬
983Other: DYT 1 Dystonia----[1] 6 💬
984Other: DYT 1 Dystonia (Healthy Control)----[1] 6 💬
985Other: e-Monitoring----[1] 97 💬
986Other: early use of Ravulizumab[1] Ravulizumab[1] Ravulizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 11 💬
987Other: Eating Assessment Tool 10----[1] 2 💬
988Other: Eating Assessment Tool-10----[1] 2 💬
989Other: Eculizumab[1] Eculizumab[1] Eculizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 109 💬
990Other: Education about treatment options----[2] 2, 4 💬
991Other: EEG----[1] 6 💬
992Other: EEnG Questionnaire----[1] 291 💬
993Other: EIT----[1] 228 💬
994Other: Electroencephalogram (EEG) awake and extended overnight----[1] 19 💬
995Other: electroencephalography----[1] 7 💬
996Other: electrophysiological record----[1] 10 💬
997Other: Electrophysiology measurements----[1] 3 💬
998Other: Elektro-Entero-Graphy procedure----[1] 291 💬
999Other: Elimination diet----[1] 98 💬
1000Other: eltrombopag[1] Eltrombopag[2] Eltrombopag olamine ,
Eltrombopag choline 💬 		[1] MPL 💬 [3] Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬[1] 60 💬
1001Other: Empiric use of Calcium Carbonate and Calcitriol[3] Calcitriol,
Calcium,
Calcium carbonate		[3] Calcitriol ,
Calcium carbonate ,
Calcium carbonate 💬 		[1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 235 💬
1002Other: End tidal CO2 (EtCO2)----[1] 299 💬
1003Other: Endurance----[1] 6 💬
1004Other: enteral nutrition----[1] 96 💬
1005Other: Environmental factor monitoring----[1] 97 💬
1006Other: Epicardial adipose tissue measurement on the available tododensitometry used for coronary calcium scoring[1] Calcium---[1] 265 💬
1007Other: Epiduroscopy----[1] 70 💬
1008Other: Epistaxis charts----[1] 227 💬
1009Other: Essential Oil Blend (Lavender, Rosemary)[1] Rosemary---[1] 13 💬
1010Other: Estimation of Pentraxin3----[1] 46 💬
1011Other: EUS procedure----[1] 298 💬
1012Other: Evaluate the blood level of NTproBNP----[1] 97 💬
1013Other: Evaluation by Investigator----[1] 6 💬
1014Other: Evaluation of body composition and metabolism----[1] 3 💬
1015Other: Evaluation of degree chronic fatigue.----[1] 13 💬
1016Other: Evaluation of lower extremity muscle strength, physical activity, exercise capacity, balance, quality of life, and fatigue in healthy controls----[1] 13 💬
1017Other: Evaluation of lower extremity muscle strength, physical activity, exercise capacity, balance, quality of life, and fatigue in POMS----[1] 13 💬
1018Other: evaluation of muscle function----[1] 3 💬
1019Other: Event-related evoked potential using electroencephalography (EEG).----[1] 6 💬
1020Other: Examination----[3] 46, 49, 51 💬
1021Other: Excipient----[1] 2 💬
1022Other: Exclusion Diet----[1] 96 💬
1023Other: Exclusive enteral nutrition----[1] 96 💬
1024Other: excreta----[1] 222 💬
1025Other: exercise and blood tests----[1] 193 💬
1026Other: Exercise capacity----[1] 299 💬
1027Other: Exercise echocardiography----[1] 58 💬
1028Other: Exercise followed cold water immersion[1] Water[1] Water 💬 --[1] 46 💬
1029Other: Exercise group----[1] 271 💬
1030Other: Exercise in water[1] Water[1] Water 💬 --[1] 6 💬
1031Other: Exercise intervention----[3] 13, 18, 60 💬
1032Other: Exercise Training----[1] 113 💬
1033Other: Exercise, physical therapy, occupational therapy, speech therapy, sauna, EMS, massage and other therapies----[2] 2, 4 💬
1034Other: Exergaming----[1] 149 💬
1035Other: explanted liver of BA patients sampling----[1] 296 💬
1036Other: Exposure to methylprednisolone during pregnancy[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1037Other: extraction of blood samples----[1] 19 💬
1038Other: FACIT-F and Pain Scales----[1] 34 💬
1039Other: Faecal bacterial transplantation----[1] 97 💬
1040Other: Familial Mediterranean Fever Quality of life scale----[1] 266 💬
1041Other: fatigue----[1] 13 💬
1042Other: Fear of falling----[1] 13 💬
1043Other: Fecal Microbial Transplantation----[2] 96, 97 💬
1044Other: Fecal microbiota transplant[1] Fecal microbiota---[1] 97 💬
1045Other: Fecal Microbiota transplant (FMT)[1] Fecal microbiota---[1] 97 💬
1046Other: Fecal Microbiota Transplantation[1] Fecal microbiota---[3] 96, 97, 271 💬
1047Other: Fecal Microbiota Transplantation (FMT)[1] Fecal microbiota---[2] 13, 97 💬
1048Other: Fecal Microbiota Transplantation Capsules[1] Fecal microbiota---[1] 97 💬
1049Other: First-line cognitive assessment----[1] 3 💬
1050Other: Fish intake----[1] 46 💬
1051Other: Fitbit Activity Monitor----[1] 49 💬
1052Other: flow cytometry----[5] 28, 51, 60, 65, 285 💬
1053Other: Fluid Restriction----[1] 72 💬
1054Other: Fluorescein angiography[1] Fluorescein[2] Fluorescein ,
Fluorescein sodium 💬 		--[1] 19 💬
1055Other: Fluorescence molecular imaging procedure without prior administration of vedolizumab-800CW[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[2] 96, 97 💬
1056Other: fog----[1] 6 💬
1057Other: Follow-up study of the untreated cohort----[1] 193 💬
1058Other: Food Diary----[1] 65 💬
1059Other: Food Frequency Questionnaire----[1] 299 💬
1060Other: Food groups and Nutrients----[1] 46 💬
1061Other: food questionnaire----[4] 46, 49, 96, 97 💬
1062Other: Formalin-fixed Paraffin-embedded (FFPE) tissue samples analysis----[1] 98 💬
1063Other: Four Square Step Test----[2] 6, 13 💬
1064Other: Fractional Exhaled NO (FENO)----[1] 96 💬
1065Other: free diet----[1] 97 💬
1066Other: Fresh Frozen Plasma----[1] 14 💬
1067Other: Fruit and vegetables intake----[1] 46 💬
1068Other: Fruit juice----[1] 299 💬
1069Other: Full history , clinical examination, assesment of disease activity ,Laboratory investigations ( CBC , ESR, CRP Serum creatinine and blood urea, Random plas[1] Creatinine[1] Creatinine 💬 --[2] 46, 49 💬
1070Other: Functional involvement of identified epigenetic alterations----[1] 102 💬
1071Other: Functional mobility----[2] 6, 13 💬
1072Other: Functional Oral Intake Scale----[1] 2 💬
1073Other: Functional Reach Test----[2] 6, 13 💬
1074Other: Gadobutrol[1] Gadobutrol[1] Gadobutrol 💬 --[1] 46 💬
1075Other: Gait analysis via video capture----[2] 3, 113 💬
1076Other: Gait and balance group training----[1] 6 💬
1077Other: Gait and balance training----[1] 6 💬
1078Other: Gastrointestinal (GI) and nutrition questionnaires:----[1] 299 💬
1079Other: General and Neurological examination----[1] 19 💬
1080Other: general population----[2] 46, 271 💬
1081Other: Generation of Induced Pluripotent Stem Cells (iPSC) from fibroblasts obtained by skin biopsy----[1] 102 💬
1082Other: generation of iPSCs----[1] 21 💬
1083Other: Genetic data/DNA/RNA----[2] 49, 51 💬
1084Other: Genetic Testing----[1] 113 💬
1085Other: Genetic testing of VWF----[1] 288 💬
1086Other: GH pause----[1] 78 💬
1087Other: GIP----[1] 235 💬
1088Other: GIP + GLP-2----[2] 3, 113 💬
1089Other: glatiramer acetate[2] Acetate,
Glatiramer		[1] Glatiramer acetate 💬 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1090Other: Glatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod[7] Acetate,
Fingolimod,
Glatiramer,
Ozanimod,
Ponesimod,
Siponimod,
Teriflunomide		[10] Fingolimod hydrochloride ,
Glatiramer acetate ,
Fingolimod ,
Teriflunomide ,
Ozanimod hydrochloride ,
Ozanimod ,
Siponimod fumarate ,
Ponesimod ,
Siponimod ,
Fingolimod lauryl sulfate 💬 		[26] DHODH,
HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[37] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Efferocytosis, Endocytosis, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagocytosis, Pyrimidine metabolism, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
1091Other: GLP-2----[1] 235 💬
1092Other: Glucose----[1] 254 💬
1093Other: Glucose profile for 2 weeks----[1] 299 💬
1094Other: glucose solution at a dose of 1.75 g/kg (up to a maximum of 75 g) for the OGTT and glucose solution at a dose of 0.5 g/kg (up to a maximum of 35 g) was injected in 2.5-3 min for the IGTT----[1] 299 💬
1095Other: glucose-based sports drink----[1] 97 💬
1096Other: Glycerine gel----[1] 265 💬
1097Other: Gold Standard Questionnaire[1] Gold---[1] 291 💬
1098Other: Green tea (Camellia sinensis)----[1] 96 💬
1099Other: Groningen Anti-Inflammatory Diet (GrAID)----[1] 96 💬
1100Other: Group 1. Standard Home Blood Pressure Measurement----[1] 34 💬
1101Other: Group 2 (DMARDS treated group)----[1] 46 💬
1102Other: Group 2. Hypnosis script prior to home blood pressure measurement----[1] 34 💬
1103Other: Group B SLE one blood donation----[1] 49 💬
1104Other: Group balance training----[1] 13 💬
1105Other: Group Exercise: community setting----[1] 70 💬
1106Other: GSK2586184 single dose taken with food----[1] 49 💬
1107Other: GSK2586184 single dose taken without food----[1] 49 💬
1108Other: Gustatory sensitivity test using Taste strips----[1] 13 💬
1109Other: habitual diet -> pomegranate juice[1] Pomegranate---[1] 97 💬
1110Other: Haematopoietic Stem Cell Transplantation (HSCT)----[1] 65 💬
1111Other: hair----[2] 46, 49 💬
1112Other: Hair and nails sampling----[1] 46 💬
1113Other: Hand training----[1] 46 💬
1114Other: Handwriting, gait, speech, eye movements, biological samples (blood, urine, stool, saliva, etc.), images, EEG, and other relevant markers----[1] 6 💬
1115Other: Harkány medicinal water[1] Water[1] Water 💬 --[1] 46 💬
1116Other: Health Assessment Questionnaire (HAQ)----[1] 46 💬
1117Other: Health surveys----[2] 86, 88 💬
1118Other: healthy controls----[1] 63 💬
1119Other: Healthy volunteers----[1] 46 💬
1120Other: Heart Rate----[1] 113 💬
1121Other: hemicellulose crystalline----[1] 6 💬
1122Other: Hepatic elastography----[1] 299 💬
1123Other: High energy / protein diet.----[1] 96 💬
1124Other: High Glycemic Index Meal----[1] 299 💬
1125Other: High intensity exercise and balance training----[1] 6 💬
1126Other: High intensity resistance training----[1] 46 💬
1127Other: high performance liquid chromatography----[1] 96 💬
1128Other: High resolution peripheral quantitative computed tomography (HRpQCT)----[1] 172 💬
1129Other: High Water Intake[1] Water[1] Water 💬 --[1] 67 💬
1130Other: High-intensity training in shallow and deep water[1] Water[1] Water 💬 --[1] 6 💬
1131Other: Histamine[1] Histamine[3] Histamine dihydrochloride ,
Histamine phosphate ,
Histamine 💬 		[4] HRH1,
HRH2,
HRH3,
HRH4 💬 		[5] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
1132Other: Histone acetylation profiles of cells of SRT patients with CREBBP mutations----[1] 102 💬
1133Other: Historical control----[1] 2 💬
1134Other: Historical data of lipid-lowering drug administration----[1] 79 💬
1135Other: Historical data of plasma lipids, xanthoma changes----[1] 79 💬
1136Other: Hoehn and Yahr Scale----[1] 6 💬
1137Other: Home functional balance physiotherapy----[1] 6 💬
1138Other: Home Hand Held Spirometry----[1] 85 💬
1139Other: Honey[1] Honey[1] Honey 💬 --[1] 98 💬
1140Other: Hospital anxiety and depression scale----[1] 266 💬
1141Other: HUMAC Balance System for Postural stability evaluation----[1] 149 💬
1142Other: Human Milk Derived Fortifier----[1] 210 💬
1143Other: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)----[1] 63 💬
1144Other: Human umbilical cord-derived MSCs and cyclosporin A----[1] 60 💬
1145Other: Human/Bovine Milk----[1] 210 💬
1146Other: Hydrocortisone[1] Hydrocortisone[1] Hydrocortisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 75 💬
1147Other: Hydrogen peroxide[2] Hydrogen,
Hydrogen peroxide		[1] Hydrogen peroxide 💬 --[1] 13 💬
1148Other: Hydroxychloroquine/Chloroquine[2] Chloroquine,
Hydroxychloroquine		[6] Hydroxychloroquine sulfate ,
Chloroquine phosphate ,
Chloroquine ,
Chloroquine hydrochloride ,
Chloroquine sulfate ,
Hydroxychloroquine 💬 		--[1] 46 💬
1149Other: Hyperbaric oxygen[1] Oxygen[1] Oxygen 💬 --[1] 96 💬
1150Other: Hyperbaric Oxygen Therapy[1] Oxygen[1] Oxygen 💬 --[2] 97, 226 💬
1151Other: Hyperbaric Oxygen Therapy (HBOT)[1] Oxygen[1] Oxygen 💬 --[1] 71 💬
1152Other: Hyperpolarized 129Xe MRI----[2] 84, 231 💬
1153Other: Hyperpolarized Xenon MRI[1] Xenon[2] Xenon ,
Xenon Xe 133 💬 		--[1] 299 💬
1154Other: Hypoglycemic Clamp----[1] 299 💬
1155Other: Hypothyroidism QOL questionnaire----[1] 80 💬
1156Other: IBD-AID diet----[1] 96 💬
1157Other: Ibuprofen[1] Ibuprofen[5] Ibuprofen ,
Ibuprofen aluminum ,
Ibuprofen lysine ,
Ibuprofen sodium ,
Ibuprofen sodium 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 96 💬
1158Other: Ibuprofen and Isosorbide Dinitrate combination[3] Ibuprofen,
Isosorbide,
Isosorbide dinitrate		[7] Ibuprofen ,
Isosorbide ,
Isosorbide dinitrate ,
Ibuprofen aluminum ,
Ibuprofen lysine ,
Ibuprofen sodium ,
Ibuprofen sodium 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 113 💬
1159Other: Iloprost (Ventavis inhaled, BAYQ6256)[1] Iloprost[2] Iloprost ,
Iloprost tromethamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
1160Other: Imaging----[1] 13 💬
1161Other: imaging test----[1] 265 💬
1162Other: Imitation (sham) surgery----[1] 8 💬
1163Other: Imitation Surgical Procedure (ISP)----[1] 6 💬
1164Other: immunologic technique----[3] 49, 65, 285 💬
1165Other: Immunophenotype of leukocyte subpopulations----[1] 46 💬
1166Other: In vitro stimulation of blood with periodontitis-associated- and control bacteria----[1] 46 💬
1167Other: inactive drug----[1] 226 💬
1168Other: Inclisiran[1] Inclisiran[2] Inclisiran ,
Inclisiran sodium 💬 		[1] PCSK9 💬 [1] Cholesterol metabolism 💬[1] 79 💬
1169Other: Incontinence Severity----[1] 13 💬
1170Other: Indirect Calorimetry----[1] 15 💬
1171Other: Indirect calorimetry, body composition , blood tests,3 days food records,Crohns disease activity index----[1] 96 💬
1172Other: Individualized exercises: clinical setting----[1] 70 💬
1173Other: Induced expectoration----[1] 46 💬
1174Other: Induced hypotonic hyponatremia - SIAD model----[1] 72 💬
1175Other: Inert Almond Oil Massage[1] Almond---[1] 46 💬
1176Other: infliximab (IFX) infusion[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 96 💬
1177Other: Infusion rate of infliximab[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
1178Other: Inhalable Hypertonic saline 7%----[1] 299 💬
1179Other: Inhalable Hypertonic saline 7% + Hyaluronan 0.1%----[1] 299 💬
1180Other: Inhaled Hyperpolarized Xenon-129[1] Xenon[2] Xenon ,
Xenon Xe 133 💬 		--[1] 228 💬
1181Other: inspiratory muscle retraining----[1] 266 💬
1182Other: Inspiratory Muscle Training----[1] 13 💬
1183Other: Instability Resistance Training----[1] 6 💬
1184Other: Integrated Traditional Chinese and Western Medicine----[1] 46 💬
1185Other: Intensify treatment with the existing drug----[2] 96, 97 💬
1186Other: intensive supportive care----[1] 66 💬
1187Other: interferon beta1----[1] 13 💬
1188Other: interferon ß1----[1] 13 💬
1189Other: Interrogation of the subject----[1] 127 💬
1190Other: intestinal content samples and biopsies----[1] 97 💬
1191Other: Intrathecal saline injection----[1] 13 💬
1192Other: Intravesical Ozone Therapy[1] Ozone---[1] 226 💬
1193Other: Iptacopan[1] Iptacopan[2] Iptacopan ,
Iptacopan hydrochloride 💬 		[1] CFB 💬 [3] Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬[1] 223 💬
1194Other: ISA 51----[1] 50 💬
1195Other: ISA 51 VG----[1] 49 💬
1196Other: IV Methylprednisolone administration[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
1197Other: IV saline infusion----[1] 96 💬
1198Other: IV steroids combination alone----[1] 41 💬
1199Other: IVIg----[1] 35 💬
1200Other: Jenkins Sleep Evaluation Scale----[1] 266 💬
1201Other: Joint Mobilizations (spine, sacroiliac, hip)----[1] 70 💬
1202Other: Ketogenic Diet----[2] 19, 67 💬
1203Other: Kidney imaging----[1] 234 💬
1204Other: Lab Work----[1] 46 💬
1205Other: Laboratory Biomarker Analysis----[22] 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
1206Other: laboratory blood tests----[1] 46 💬
1207Other: Lactate Meter----[2] 65, 257 💬
1208Other: Land-based Liuzijue exercise----[1] 49 💬
1209Other: Language Intervention----[1] 206 💬
1210Other: Lavender Aromatherapy Massage----[1] 46 💬
1211Other: Lecanemab non-administration group[1] Lecanemab[1] Lecanemab 💬 [1] APP 💬 [4] Alzheimer disease, IgSF CAM signaling, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse 💬[1] 6 💬
1212Other: Lengthening adalimumab dosing interval[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 96 💬
1213Other: Leukapheresis- Collection of stem cells----[1] 96 💬
1214Other: Levodopa[1] Levodopa[1] Levodopa 💬 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1215Other: levothyroxine[1] Levothyroxine[3] Levothyroxine sodium ,
Levothyroxine ,
Levothyroxine sodium 💬 		[2] THRA,
THRB 💬 		[3] Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬[1] 78 💬
1216Other: Liberation therapy----[1] 13 💬
1217Other: Liquid Alpha1-PI----[1] 231 💬
1218Other: Liquid meal (Nutridrink)----[1] 235 💬
1219Other: Liquid Meal Test (Carbohydrate-rich)----[1] 299 💬
1220Other: Liquid Meal Test (Fat-rich)----[1] 299 💬
1221Other: Liquid Meal Test (Mixed)----[1] 299 💬
1222Other: Liver Evaluation----[1] 240 💬
1223Other: Liver questionnaire----[1] 231 💬
1224Other: Local injection of normal saline----[1] 96 💬
1225Other: Losartan[1] Losartan[2] Losartan potassium ,
Losartan 💬 		[1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 46 💬
1226Other: Low Blood Pressure Control----[1] 67 💬
1227Other: Low dose (1 mcg) ACTH stimulation test----[1] 193 💬
1228Other: Low Glycemic Index Meal----[1] 299 💬
1229Other: Low intensity resistance training combined with blood flow restriction----[1] 46 💬
1230Other: Low n-6 PUFA Diet----[1] 96 💬
1231Other: low satured diet----[1] 79 💬
1232Other: Low-Fat Control Diet----[1] 124 💬
1233Other: Low-intensity exercise therapy----[1] 298 💬
1234Other: Low-Load Exercise Control Group----[1] 13 💬
1235Other: Low-Load Exercise with Blood Flow Restriction----[1] 13 💬
1236Other: Lower Limb Strength----[1] 6 💬
1237Other: LPS Challenge----[1] 84 💬
1238Other: lumbar puncture for CSF sampling----[1] 127 💬
1239Other: lung function tests----[1] 230 💬
1240Other: Lupus Impact Tracker questionnaire----[1] 49 💬
1241Other: Lyophilized Fecal Microbiota Transplantation (LFMT)[1] Fecal microbiota---[1] 97 💬
1242Other: Magnetic Resonance Imaging----[2] 13, 15 💬
1243Other: Mangafodipir trisodium[1] Mangafodipir[2] Mangafodipir trisodium ,
Mangafodipir 💬 		--[2] 57, 58 💬
1244Other: Manual Infusion of Remimazolam[1] Remimazolam[2] Remimazolam besylate ,
Remimazolam 💬 		[16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 22 💬
1245Other: Matching vehicle control----[1] 98 💬
1246Other: MCIT program----[1] 22 💬
1247Other: Meal Challenge----[1] 240 💬
1248Other: Meal test----[2] 3, 113 💬
1249Other: measure of endothelial function----[1] 299 💬
1250Other: Measurement of blood immune populations and microbiota distribution.----[1] 222 💬
1251Other: Measurement of drug (Adalimumab/Infliximab)[2] Adalimumab,
Infliximab		[2] Adalimumab ,
Infliximab 💬 		[1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 96, 97 💬
1252Other: Measurement of exercise-induced fatigue----[1] 113 💬
1253Other: Measurement of heart rate variability.----[1] 46 💬
1254Other: Measurement of multifidus and gastrocnemius muscle thickness with Ultrasound----[1] 149 💬
1255Other: Meat intake----[1] 46 💬
1256Other: Medical air[1] Medical air[1] Air, medical 💬 --[1] 85 💬
1257Other: medical chart review----[1] 60 💬
1258Other: Medical history questionnaire----[1] 23 💬
1259Other: Medical History Questionnaires----[1] 65 💬
1260Other: Medication Compliance Phone Call----[1] 98 💬
1261Other: Medication Diary----[1] 13 💬
1262Other: Mediterranean Diet----[2] 97, 299 💬
1263Other: Mediterranean Diet with Extra Virgin Olive Oil[1] Olive oil[1] Olive oil 💬 --[1] 124 💬
1264Other: Mediterranean Diet with Walnuts----[1] 124 💬
1265Other: Medium Protein Diet (MPD)----[1] 222 💬
1266Other: Mesalazine[1] Mesalazine[1] Mesalamine 💬 --[1] 97 💬
1267Other: Metformin[1] Metformin[2] Metformin hydrochloride ,
Metformin 💬 		[2] PRKAA1,
PRKAA2 💬 		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[1] 46 💬
1268Other: Methacholine Challenge Test[1] Methacholine[1] Methacholine chloride 💬 [5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 96 💬
1269Other: Methotrexate therapy[1] Methotrexate[2] Methotrexate ,
Methotrexate sodium 💬 		[2] DHFR,
DHFR2 💬 		[3] Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬[1] 46 💬
1270Other: MIBG label with I123 or I124----[1] 6 💬
1271Other: Microindentation----[1] 172 💬
1272Other: micromethod from samples taken from blood spots on filter paper----[1] 19 💬
1273Other: miRNAs isolation from blood samples of patients and control----[1] 299 💬
1274Other: mitoxantrone - immunomodulator[1] Mitoxantrone[2] Mitoxantrone hydrochloride ,
Mitoxantrone 💬 		--[1] 13 💬
1275Other: Mixed meal test evaluation test arm----[1] 299 💬
1276Other: Mixed Meal Tolerance Test----[1] 299 💬
1277Other: MMF Discontinuation----[7] 46, 49, 50, 51, 53, 56, 107 💬
1278Other: MMF maintain----[7] 46, 49, 50, 51, 53, 56, 107 💬
1279Other: Mobile platform exercise----[1] 6 💬
1280Other: Mobility study in dry conditions----[1] 3 💬
1281Other: Mobility study in water conditions[1] Water[1] Water 💬 --[1] 3 💬
1282Other: Mobilization----[1] 121 💬
1283Other: Mock injection----[1] 90 💬
1284Other: modified Atkins diet----[1] 145 💬
1285Other: Modified Mixed Meal Tolerance Test----[1] 65 💬
1286Other: Modified Oral Glucose Tolerance Test----[1] 65 💬
1287Other: Modified paleolithic diet----[1] 13 💬
1288Other: Monthly assessments of functional motor abilities by a trained therapist----[1] 3 💬
1289Other: Motor assessment----[1] 6 💬
1290Other: Motor Assessments before taking regular PD treatment----[1] 6 💬
1291Other: Motor Assessments on regular PD treatment----[1] 6 💬
1292Other: Motor Imagery as compared to physical practice for balance tasks----[1] 13 💬
1293Other: Motor Milestone Assessments----[2] 111, 113 💬
1294Other: Motor training program----[1] 22 💬
1295Other: Moviplate----[1] 113 💬
1296Other: MP+DDCI----[1] 6 💬
1297Other: MP-Equivalent----[1] 6 💬
1298Other: MP-Low----[1] 6 💬
1299Other: MRI----[4] 3, 13, 127, 206 💬
1300Other: MRI scan----[1] 6 💬
1301Other: MRI, dual-energy, x-ray absorptiometry, muscle ultrasounds, blood testing----[2] 75, 77 💬
1302Other: MSCs----[1] 13 💬
1303Other: MTX Discontinuation----[7] 46, 49, 50, 51, 53, 56, 107 💬
1304Other: MTX maintain----[7] 46, 49, 50, 51, 53, 56, 107 💬
1305Other: Multidisciplinary intensive rehabilitation treatment----[1] 6 💬
1306Other: Multiple----[1] 140 💬
1307Other: Multiple Sclerosis patients who have been on Ocrelizumab will undergo cognitive and fatigue assessments[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1308Other: Muscle Biopsy----[1] 46 💬
1309Other: Muscle Biopsy (Safety)----[1] 113 💬
1310Other: Muscle MRI----[2] 3, 10 💬
1311Other: Muscle oxygenation----[1] 299 💬
1312Other: Muscle strengthening----[1] 121 💬
1313Other: Music----[1] 6 💬
1314Other: myBETAapp----[1] 13 💬
1315Other: MyoAnkle----[1] 113 💬
1316Other: N-thymidine[1] Thymidine[1] Doxribtimine 💬 [1] TK2 💬 [2] Drug metabolism - other enzymes, Pyrimidine metabolism 💬[2] 215, 216 💬
1317Other: N15-thymidine[1] Thymidine[1] Doxribtimine 💬 [1] TK2 💬 [2] Drug metabolism - other enzymes, Pyrimidine metabolism 💬[1] 215 💬
1318Other: nasal epithelial----[1] 299 💬
1319Other: Natalizumab[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1320Other: Natalizumab discontinuation[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1321Other: Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsq[8] Alemtuzumab,
Cladribine,
Hyaluronidase,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Rituximab,
Ublituximab		[10] Cladribine ,
Alemtuzumab ,
Rituximab ,
Hyaluronidase ,
Hyaluronidase ,
Ocrelizumab ,
Hyaluronidase ,
Natalizumab ,
Ofatumumab ,
Ublituximab 💬 		[3] ITGA4,
MS4A1,
RRM1 💬 		[21] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Focal adhesion, Glutathione metabolism, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
1322Other: natural herbs of coconut, aloe vera, and pepperint[1] Coconut---[1] 53 💬
1323Other: NBT-NM108 (0 g/day)----[1] 13 💬
1324Other: NeoKare Breast Milk Fortifier----[1] 291 💬
1325Other: Neupro 4 mg / 24 Hr. Transdermal Patch----[1] 6 💬
1326Other: Neurocognitive assessment----[1] 6 💬
1327Other: Neurocognitive examination for healthy subjects----[1] 13 💬
1328Other: Neurologic / neuropsychologic tests - Controls----[1] 13 💬
1329Other: Neurologic / neuropsychologic tests - Patients----[1] 13 💬
1330Other: Neurological assessments----[1] 2 💬
1331Other: Neurology exam----[1] 19 💬
1332Other: Neuromuscular evaluation----[1] 13 💬
1333Other: Neuropsychological Assessment----[1] 280 💬
1334Other: Neuropsychological assessments----[1] 34 💬
1335Other: Neuropsychological tests----[1] 13 💬
1336Other: Neutral Carrier Oil (Apricot Kernel Oil)[2] Apricot,
Apricot kernel oil		---[1] 13 💬
1337Other: Nil per os----[1] 291 💬
1338Other: Nintendo Wii Fit Balance exercises----[1] 13 💬
1339Other: NIO752----[1] 5 💬
1340Other: No active treatment----[1] 274 💬
1341Other: No anti-inflammatory treatment----[1] 271 💬
1342Other: No doxycycline[1] Doxycycline[5] Doxycycline ,
Doxycycline hyclate ,
Doxycycline calcium ,
Doxycycline ,
Doxycycline hydrochloride 💬 		--[1] 299 💬
1343Other: No enzyme therapy----[1] 298 💬
1344Other: No intervention----[5] 6, 70, 96, 97, 201 💬
1345Other: No intervention (Follow-Up assessment)----[1] 90 💬
1346Other: No intervention, just collect blood samples and CSF samples----[1] 13 💬
1347Other: No intervention, will not receive any active study intervention----[2] 90, 303 💬
1348Other: No intervention- observational sub-study----[1] 226 💬
1349Other: No Intervention: Standard of Care----[1] 85 💬
1350Other: No Investigational Product----[1] 19 💬
1351Other: No IT treatment----[1] 19 💬
1352Other: No MSDMDs therapy (control)----[1] 13 💬
1353Other: No pancreatic enzyme replacement therapy----[1] 299 💬
1354Other: No Plasma Exchange----[2] 43, 44 💬
1355Other: No study treatments administered - blood draws only----[1] 13 💬
1356Other: No treatment----[2] 53, 274 💬
1357Other: No Treatment (Healthy Controls)----[1] 271 💬
1358Other: No Treatment Arm----[1] 13 💬
1359Other: Non-exposed group----[1] 97 💬
1360Other: non-genotyping----[1] 97 💬
1361Other: Non-hormonal period----[1] 299 💬
1362Other: Non-Motor Symptoms----[1] 6 💬
1363Other: Noninvasive actigraphy monitor----[1] 86 💬
1364Other: Nordic walking (only osteoporosis group)----[1] 6 💬
1365Other: Normal (control) diet----[1] 240 💬
1366Other: normal diet----[2] 96, 97 💬
1367Other: normal saline----[5] 13, 97, 222, 226, 280 💬
1368Other: Normal Saline for injection----[1] 84 💬
1369Other: Normal Saline IV Administration----[1] 65 💬
1370Other: Normal Saline Solution 0.9%----[1] 107 💬
1371Other: NS----[1] 96 💬
1372Other: Numerical rating scale----[1] 46 💬
1373Other: Nutrition counseling----[1] 298 💬
1374Other: Nutrition specialist----[1] 97 💬
1375Other: Nutritional assessment----[2] 6, 127 💬
1376Other: Obese----[1] 75 💬
1377Other: Observation----[1] 265 💬
1378Other: Observation of Ocrelizumab as Treatment in RRMS Patients[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1379Other: observation of the adverse outcomes of Cyclosporine in steroid dependent and frequent relapsing nephrotic syndrome in children[1] Cyclosporine[1] Cyclosporine 💬 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222 💬
1380Other: Observation Only----[1] 331 💬
1381Other: Observational----[1] 90 💬
1382Other: Observational cohort----[1] 6 💬
1383Other: Observational Control----[1] 13 💬
1384Other: Ocrelizumab[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1385Other: Ofatumumab[1] Ofatumumab[1] Ofatumumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1386Other: OGTT----[1] 299 💬
1387Other: olfactory swab sampling with nasal brush----[1] 127 💬
1388Other: On-demand treatment----[1] 299 💬
1389Other: Onasemnogene Abeparvovec[1] Onasemnogene abeparvovec[1] Onasemnogene abeparvovec 💬 --[1] 3 💬
1390Other: One time survey----[1] 3 💬
1391Other: One week food diary generated by weighing foods----[1] 227 💬
1392Other: One-leg Stance Test----[1] 13 💬
1393Other: one-time peripheral blood collection----[1] 179 💬
1394Other: Ophthalmologic examinations----[1] 299 💬
1395Other: Optimized Supportive Care----[1] 66 💬
1396Other: Optional Blood-Oxygen-level Dependent functionalMRI[1] Oxygen[1] Oxygen 💬 --[1] 6 💬
1397Other: Oral Glucose tolerance test----[3] 160, 195, 299 💬
1398Other: Oral Glucose Tolerance Test (OGTT)----[1] 77 💬
1399Other: Oral Glucose Tolerance Test (OGTT) assessment arm----[1] 299 💬
1400Other: oral glucose tolerance testing----[1] 77 💬
1401Other: Oral glucose tolerance testing (OGTT)----[1] 299 💬
1402Other: Oral Nitric Oxide testing[1] Nitric Oxide[1] Nitric oxide 💬 --[1] 98 💬
1403Other: Oromotor function and nutrition----[2] 111, 113 💬
1404Other: Otago Exercise Program only----[1] 13 💬
1405Other: Other Biologic Agents----[2] 96, 97 💬
1406Other: Other biological samples to biobank (skin, lung and muscle biopsies----[2] 49, 51 💬
1407Other: Other disease modifying therapies----[1] 13 💬
1408Other: Other intervention(s)----[1] 70 💬
1409Other: Other: Disease modifying therapies (DMT)----[1] 13 💬
1410Other: Other: Symptomatic treatment of ALS----[1] 2 💬
1411Other: Outpatient rheumatology department----[1] 46 💬
1412Other: Overnight metyrapone test[1] Metyrapone[1] Metyrapone 💬 [1] CYP11B1 💬 [3] Cortisol synthesis and secretion, Cushing syndrome, Steroid hormone biosynthesis 💬[1] 193 💬
1413Other: Oxygen[1] Oxygen[1] Oxygen 💬 --[1] 85 💬
1414Other: Oxygen (2Liter/min)[1] Oxygen[1] Oxygen 💬 --[1] 85 💬
1415Other: Oxygen (4Liter/min)[1] Oxygen[1] Oxygen 💬 --[1] 85 💬
1416Other: Oxygen - Air[1] Oxygen[1] Oxygen 💬 --[1] 299 💬
1417Other: Oxygen Administration[1] Oxygen[1] Oxygen 💬 --[1] 88 💬
1418Other: ozone therapy[1] Ozone---[1] 51 💬
1419Other: Packing----[1] 227 💬
1420Other: pain----[1] 13 💬
1421Other: Pain assessment----[1] 46 💬
1422Other: Pain questionnaires----[1] 97 💬
1423Other: Palliative Care----[6] 19, 65, 121, 160, 308, 326 💬
1424Other: PAQ-C (Physical activitiy questionare for children), MoCA (Montreal Cognitive Assessment), PBS (Pediatric Balance Scale), Modified Mini Mental State Examination, BMI (Body Mass Index)----[1] 113 💬
1425Other: Parkinson mPower mobile application----[1] 6 💬
1426Other: Partial enteral nutrition (PEN)----[1] 97 💬
1427Other: Participant follow-up----[1] 23 💬
1428Other: Passive Stretching----[1] 121 💬
1429Other: Patient questionnaires----[3] 46, 49, 51 💬
1430Other: Patient questions----[1] 46 💬
1431Other: Patient Report Outcomes Measures----[1] 10 💬
1432Other: Patient Reported Outcomes----[1] 46 💬
1433Other: Patients diagnosed with generalized myasthenia gravis and treated with Rozanolixizumab[1] Rozanolixizumab[1] Rozanolixizumab 💬 --[1] 11 💬
1434Other: PBO----[1] 50 💬
1435Other: pCCLChimGp91lentiviral vector containing the human gp91 phox (CYBB) gene----[1] 65 💬
1436Other: PCDAI----[1] 96 💬
1437Other: PD exercise intervention----[1] 6 💬
1438Other: PD vitamin + exercise----[1] 6 💬
1439Other: PEAK----[1] 13 💬
1440Other: Peanut Butter[1] Peanut---[1] 13 💬
1441Other: Pelvic floor physical therapy----[1] 226 💬
1442Other: PENTASA (mesalamine/ 5-Aminosalicylic acid (5-ASA)[1] Aminosalicylic acid[1] Aminosalicylic acid 💬 --[1] 97 💬
1443Other: Pentosan Polysulphate----[1] 226 💬
1444Other: Performed 2 diagnostic tests (2 OGTT tests with 75g of Glucose)----[1] 77 💬
1445Other: Periodized exercise training----[1] 13 💬
1446Other: peripheral blood and bone marrow withdrawal----[1] 63 💬
1447Other: Peripheral Blood Collection for Immune Profiling----[1] 84 💬
1448Other: Peripheral Blood Stem Cells----[2] 60, 62 💬
1449Other: Personalized B-fructan diet----[1] 97 💬
1450Other: Personalized pectin diet[1] Pectin[1] Pectin 💬 --[1] 97 💬
1451Other: PET-MRI exam with administration of [11C]Carfentanil[1] Carfentanil[2] Carfentanil citrate ,
Carfentanil 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 6 💬
1452Other: PET-MRI exam with administration of [11C]Yohimbine[1] Yohimbine[2] Yohimbine hydrochloride ,
Yohimbine 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 6 💬
1453Other: Pharmacogenomic Study----[1] 26 💬
1454Other: Pharmacokinetic analysis----[1] 49 💬
1455Other: Pharmacological Study----[7] 28, 34, 62, 74, 89, 232, 331 💬
1456Other: Phenylalanine (Phe)-restricted diet[1] Phenylalanine[1] Phenylalanine 💬 --[1] 240 💬
1457Other: Physalis angulata ethanol extract[1] Ethanol[2] Alcohol ,
Ethanol 💬 		--[1] 51 💬
1458Other: Physical and emotional support----[2] 2, 4 💬
1459Other: Physical Function Performance Test----[1] 6 💬
1460Other: Physical Therapy----[2] 6, 70 💬
1461Other: Picture of the feet----[1] 46 💬
1462Other: PiggyBac Transposon-Mediated CD19 CAR-T Therapy----[1] 49 💬
1463Other: Pittsburgh Compound B [11C]-PIB[1] Pittsburgh Compound B---[1] 6 💬
1464Other: PK microsampling of blood----[4] 6, 8, 13, 97 💬
1465Other: Plant-based diet----[1] 46 💬
1466Other: plasticity-based computerized cognitive remediation program----[1] 13 💬
1467Other: platelet count and mean platelet volume are obtained from whole blood count[1] Whole Blood[1] Blood, whole 💬 --[1] 299 💬
1468Other: Platelet Rich Plasma[1] Platelet Rich Plasma---[1] 70 💬
1469Other: PNF----[1] 13 💬
1470Other: polyethylene glycol preparation[1] Polyethylene glycol[3] Polyethylene glycol 3350 ,
Macrogol 4000 ,
Macrogol 6000 💬 		--[1] 96 💬
1471Other: polymerase chain reaction (PCR) technique of blood transcriptome analysis----[1] 49 💬
1472Other: pomegranate juice -> habitual diet[1] Pomegranate---[1] 97 💬
1473Other: Position Sense----[1] 13 💬
1474Other: Post mortem examination----[1] 23 💬
1475Other: Postoperative nausea and vomiting at 24 hour----[1] 235 💬
1476Other: Postoperative nausea and vomiting at 6 hour----[1] 235 💬
1477Other: Postoperative pain at 24 hour----[1] 235 💬
1478Other: Postoperative pain at 6 hour----[1] 235 💬
1479Other: Postoperative sore throat and hoarseness at 24 hour----[1] 235 💬
1480Other: Postoperative sore throat and hoarseness at 6 hour----[1] 235 💬
1481Other: Posturological examination on KPlates and AMTI platforms----[1] 10 💬
1482Other: Potable water[1] Water[1] Water 💬 --[1] 19 💬
1483Other: prednisone[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
1484Other: pretreatment antibiotics----[1] 97 💬
1485Other: Progressive exercise----[1] 13 💬
1486Other: Progressive resisted exercise training----[1] 49 💬
1487Other: PROMIS instruments----[1] 49 💬
1488Other: propensity score----[1] 13 💬
1489Other: Prospective observational registry----[1] 3 💬
1490Other: PSP----[1] 13 💬
1491Other: Psychiatric evaluation----[1] 48 💬
1492Other: Psychosocial questionnaire: Additional Health Questionnaire----[1] 299 💬
1493Other: Psychosocial questionnaire: Body Esteem Scale for Adolescents and Adults (BESAA)----[1] 299 💬
1494Other: Psychosocial questionnaire: CF Fatalism Scale----[1] 299 💬
1495Other: Psychosocial questionnaire: GAD-7----[1] 299 💬
1496Other: Psychosocial questionnaire: PHQ-8----[1] 299 💬
1497Other: Psychosocial questionnaire: The Treatment Self-Regulation Questionnaire (TSRQ)----[1] 299 💬
1498Other: Psyllium husks----[1] 46 💬
1499Other: PTH based Calcium Carbonate and Calcitriol repletion[3] Calcitriol,
Calcium,
Calcium carbonate		[3] Calcitriol ,
Calcium carbonate ,
Calcium carbonate 💬 		[1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 235 💬
1500Other: Pulmonary Exercise Test----[1] 86 💬
1501Other: Pulmonary Function Test----[1] 113 💬
1502Other: Pulmonary Function Tests----[1] 84 💬
1503Other: Pulmonary rehabilitation program----[1] 85 💬
1504Other: Purdue board test----[1] 113 💬
1505Other: QALCIMUM questionnaire----[2] 13, 46 💬
1506Other: QOL assessment, Neuropsychological----[1] 111 💬
1507Other: Quality of life assessment----[1] 122 💬
1508Other: Quality of Life questionnaire----[1] 19 💬
1509Other: Quality of Life Questionnaires----[3] 85, 111, 234 💬
1510Other: Quality-of-Life Assessment----[9] 34, 36, 51, 62, 65, 96, 284, 286, 298 💬
1511Other: Quantification of myotonia----[1] 113 💬
1512Other: Quantitative neuromuscular MRI----[1] 10 💬
1513Other: quercetin[1] Quercetin---[1] 299 💬
1514Other: Questionnaire----[4] 85, 93, 94, 106 💬
1515Other: Questionnaire Administration----[7] 16, 28, 34, 51, 60, 97, 298 💬
1516Other: Questionnaire on dietary history----[1] 227 💬
1517Other: Questionnaire on nosebleed severity----[1] 227 💬
1518Other: Questionnaire, fasting blood sample----[2] 93, 94 💬
1519Other: Questionnaire, semen sample, fasting blood sample----[2] 93, 94 💬
1520Other: Questionnaires----[8] 3, 6, 13, 41, 46, 77, 96, 226 💬
1521Other: Questionnaires on quality of life, pain and disability----[1] 51 💬
1522Other: Randomized B-fructan diet----[1] 97 💬
1523Other: Rapamycin----[1] 158 💬
1524Other: Reaction Time and Postural Control----[1] 299 💬
1525Other: Reactive Balance Training----[1] 149 💬
1526Other: Real-time data capture app----[1] 46 💬
1527Other: Recifercept[1] Recifercept[1] Recifercept 💬 [1] FGFR3 💬 [12] Bladder cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬[1] 276 💬
1528Other: Recommendation with regard to nutrition----[1] 6 💬
1529Other: Red Blood Cell Transfusion----[1] 248 💬
1530Other: Reduction group 1----[1] 46 💬
1531Other: Reduction group 2----[1] 46 💬
1532Other: Refered to general practice----[1] 46 💬
1533Other: Registry----[4] 6, 8, 13, 97 💬
1534Other: Removal of blood----[2] 96, 97 💬
1535Other: Repeat MRI scan----[1] 113 💬
1536Other: Research Blood Sampling----[1] 210 💬
1537Other: Research Testing Performed----[1] 46 💬
1538Other: research-specific blood sample----[1] 265 💬
1539Other: Resistance Exercise Program----[1] 46 💬
1540Other: Respiratory symptom questionnaire: CRISS----[1] 299 💬
1541Other: Resveratrol[1] Resveratrol---[1] 57 💬
1542Other: Review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry.[1] Melatonin[1] Melatonin 💬 [2] MTNR1A,
MTNR1B 💬 		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 149 💬
1543Other: Rheumatic diseases Mistreatment Scale (RDMS)----[1] 46 💬
1544Other: Rhythmic Balance-Movement Training (rBMT)----[1] 6 💬
1545Other: RMST----[1] 256 💬
1546Other: Rosemary essential oil[1] Rosemary---[1] 51 💬
1547Other: Rotigotine[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1548Other: Routine----[1] 240 💬
1549Other: Routine assessment of patient index data 3 (RAPID-3)----[1] 46 💬
1550Other: Routine blood samples----[1] 240 💬
1551Other: routine management----[1] 291 💬
1552Other: routine therapy----[1] 299 💬
1553Other: Salbutamol nebulisation and with CPAP----[1] 228 💬
1554Other: Saline----[8] 2, 6, 46, 97, 98, 256, 274, 301 💬
1555Other: Saline as a nasal spray----[1] 226 💬
1556Other: Saline Challenge----[1] 84 💬
1557Other: saline solution----[2] 46, 67 💬
1558Other: Saline solution.----[1] 67 💬
1559Other: saliva collection----[1] 46 💬
1560Other: Sample blood and 2D-echocardiography with Doppler----[2] 19, 58 💬
1561Other: sample blood and fecal collection----[1] 97 💬
1562Other: sampling blood----[1] 2 💬
1563Other: Schirmer test----[1] 46 💬
1564Other: Screening to prevent falls----[1] 6 💬
1565Other: second-line cognitive assessment----[1] 3 💬
1566Other: Secukinumab[1] Secukinumab[1] Secukinumab 💬 [1] IL17A 💬 [6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬[2] 107, 271 💬
1567Other: Selective Motor Control Evaluation for the upper and lower extremities----[1] 149 💬
1568Other: Sending a link to the video----[1] 84 💬
1569Other: sequential fecal microbiota transplant combined with small intestinal fluid transplant[1] Fecal microbiota---[1] 99 💬
1570Other: Serum calcium concentrations results[1] Calcium---[1] 235 💬
1571Other: serum levels of angiogenin, bFGF, VEGF----[1] 56 💬
1572Other: SF-12 questionnaire----[3] 13, 51, 56 💬
1573Other: SF-36 and HADS----[1] 74 💬
1574Other: SF-36 questionnaire----[1] 49 💬
1575Other: Sham (no implant)----[1] 90 💬
1576Other: Sham (No Treatment)----[1] 302 💬
1577Other: Sham abdominal compression----[1] 17 💬
1578Other: Sham Comparator----[2] 140, 299 💬
1579Other: Sham Diet----[2] 96, 97 💬
1580Other: Sham Intravitreal Injection----[1] 302 💬
1581Other: Sham Oxygen therapy[1] Oxygen[1] Oxygen 💬 --[2] 86, 88 💬
1582Other: Sham procedure----[1] 90 💬
1583Other: Sham Surgery----[1] 6 💬
1584Other: Sham transplantation----[2] 96, 97 💬
1585Other: Sham-procedure----[2] 90, 303 💬
1586Other: Sham-procedure (dose cohort 1&2 only)----[2] 90, 303 💬
1587Other: Shu Bi Ning (modified Si Miao Xiao Bi)----[1] 46 💬
1588Other: Simvastatin[1] Simvastatin[1] Simvastatin 💬 [1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 46 💬
1589Other: single fecal microbiota transplantation[1] Fecal microbiota---[1] 97 💬
1590Other: Single-breath nitric oxide lung diffusing capacity measurements according to type of device in random order.[1] Nitric Oxide[1] Nitric oxide 💬 --[1] 51 💬
1591Other: Siponimod[1] Siponimod[2] Siponimod fumarate ,
Siponimod 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
1592Other: Skeletal Muscle Biomechanical Property Assessment----[1] 46 💬
1593Other: Skeletal Muscle Mitochondrial Respiratory Capacity----[1] 46 💬
1594Other: Skin biopsies----[2] 36, 51 💬
1595Other: Skin biopsy----[1] 10 💬
1596Other: skin biopsy sampling----[1] 296 💬
1597Other: skin punch biopsy----[1] 127 💬
1598Other: Skin swab samples----[1] 51 💬
1599Other: Skin Tape----[1] 240 💬
1600Other: Skinfold measurement----[1] 3 💬
1601Other: SLE treatment----[1] 49 💬
1602Other: SLEDAI scores----[1] 49 💬
1603Other: slow vital capacity----[1] 2 💬
1604Other: Smartphone Application----[1] 49 💬
1605Other: Smartphone-based balance exercises----[1] 6 💬
1606Other: SoC corticosteroid - Induction Period----[1] 96 💬
1607Other: SoC corticosteroid - Tapering----[1] 96 💬
1608Other: sodium chloride[1] Sodium chloride[1] Sodium chloride 💬 --[1] 51 💬
1609Other: Sodium Chloride 0.9%[1] Sodium chloride[1] Sodium chloride 💬 --[1] 13 💬
1610Other: Somatic- and neurological examination----[1] 127 💬
1611Other: Specific SL-therapy----[1] 6 💬
1612Other: specifically design 6 month resistance training program----[1] 13 💬
1613Other: Specimen Collection----[2] 215, 216 💬
1614Other: Speech Task - Picture Description----[1] 127 💬
1615Other: Speech Task - Picture Narrative----[1] 127 💬
1616Other: Speech Task - Picture Recall----[1] 127 💬
1617Other: Spinal tap for CSF collection----[1] 18 💬
1618Other: Spinning grp----[1] 13 💬
1619Other: Spirometry----[2] 84, 86 💬
1620Other: Spleen samples----[1] 63 💬
1621Other: Sputum and blood samples----[1] 299 💬
1622Other: Sputum Culture----[1] 84 💬
1623Other: Sputum Sample----[1] 299 💬
1624Other: Squat-to-stand maneuver----[1] 58 💬
1625Other: Standard----[1] 67 💬
1626Other: Standard Blood Pressure Control----[1] 67 💬
1627Other: Standard Bronchiectasis Care----[1] 299 💬
1628Other: Standard care----[2] 227, 299 💬
1629Other: Standard Care (in control arm)----[1] 299 💬
1630Other: Standard care according to ESC 2021 guidelines----[2] 46, 49 💬
1631Other: Standard conventional Rheumatoid Arthritis Therapy----[1] 46 💬
1632Other: standard immune suppression, oral----[1] 228 💬
1633Other: Standard intervention----[1] 265 💬
1634Other: Standard medical treatment----[6] 13, 96, 97, 149, 153, 171 💬
1635Other: Standard nutrition----[1] 96 💬
1636Other: Standard of Care----[11] 13, 49, 57, 64, 79, 85, 95, 96, 97, 245, 246 💬
1637Other: Standard of Care (SOC)----[2] 40, 62 💬
1638Other: Standard of Care Only----[2] 71, 228 💬
1639Other: Standard of Care Sildenafil[1] Sildenafil[2] Sildenafil citrate ,
Sildenafil 💬 		[1] PDE5A 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[2] 90, 301 💬
1640Other: Standard steroid treatment----[1] 113 💬
1641Other: Standard therapy----[2] 49, 222 💬
1642Other: Standard Treatment----[1] 227 💬
1643Other: Standard treatment according to the Clinical protocols----[3] 49, 51, 235 💬
1644Other: Standard-of-care----[1] 86 💬
1645Other: Standardized meals----[1] 86 💬
1646Other: Standardized scales: MDS-UPDRS (Part II to IV) and RDRS----[1] 6 💬
1647Other: Static Balance Test----[1] 13 💬
1648Other: Stem Cell Transplant----[1] 96 💬
1649Other: Sterile Normal Saline (0.9% NaCl)----[1] 231 💬
1650Other: sterile saline----[1] 46 💬
1651Other: Steroid----[1] 70 💬
1652Other: stool and blood analysis----[1] 6 💬
1653Other: stool collection----[2] 46, 97 💬
1654Other: Stool Sample----[2] 6, 299 💬
1655Other: Stool samples----[3] 51, 96, 97 💬
1656Other: STOP NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID----[1] 299 💬
1657Other: Strength Testing----[1] 46 💬
1658Other: Strength training----[1] 13 💬
1659Other: Strength training in shallow water and dry land[1] Water[1] Water 💬 --[1] 6 💬
1660Other: Strength, function and activity measurements----[1] 3 💬
1661Other: Subacute hypoxic exposures----[1] 86 💬
1662Other: Subconjunctival injection of saline----[1] 90 💬
1663Other: Subcortical Stimulation----[1] 6 💬
1664Other: Subject interview----[1] 6 💬
1665Other: Sucrose taste detection test[1] Sucrose[1] Sucrose 💬 --[1] 127 💬
1666Other: Sugar pill----[1] 90 💬
1667Other: Sulfur Pool & Medicinal Mud----[1] 46 💬
1668Other: Supervised physical therapy----[1] 13 💬
1669Other: Supplemental oxygen therapy[1] Oxygen[1] Oxygen 💬 --[2] 86, 88 💬
1670Other: Surgery----[2] 74, 96 💬
1671Other: Survey Administration----[1] 28 💬
1672Other: Swallowing Quality of Life Questionnaire----[1] 2 💬
1673Other: Swallowing Related Quality of Life Questionnaire----[1] 2 💬
1674Other: Switch from Ambrisentan to Bosentan[2] Ambrisentan,
Bosentan		[3] Bosentan ,
Ambrisentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
1675Other: Symptom Survey----[1] 98 💬
1676Other: Symptomatic hypocalcaemia at 24 hour----[1] 235 💬
1677Other: Symptomatic hypocalcaemia at 6 hour----[1] 235 💬
1678Other: Symptomatic therapy----[1] 160 💬
1679Other: Synovial fluid aspiration----[1] 46 💬
1680Other: Synovial tissue sample----[1] 46 💬
1681Other: Synthetic osteoplastic material based on beta-TCP or bone autograft----[1] 70 💬
1682Other: Synthetic osteoplastic material based on ß-TCP or bone autograft----[1] 70 💬
1683Other: tafamidis 61mg (based on prescription data)[1] Tafamidis[2] Tafamidis ,
Tafamidis meglumine 💬 		[1] TTR 💬 [1] Thyroid hormone synthesis 💬[1] 28 💬
1684Other: Tampa Kinesiophobia Scale, Berg-Balance Test, International Physical Activity Questionnaire-Short Form, Falls Efficacy Scale----[1] 6 💬
1685Other: Target-Controlled Infusion (TCI) of Remimazolam[1] Remimazolam[2] Remimazolam besylate ,
Remimazolam 💬 		[16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 22 💬
1686Other: Taste tests----[2] 6, 127 💬
1687Other: Tea consumption----[1] 46 💬
1688Other: Technetium [Tc-99m] sulfur colloid and Indium [In-111] DTPA[1] Indium---[1] 299 💬
1689Other: Telephone Interview----[1] 46 💬
1690Other: Telerehabilitation Based Functional Balance and Mobility Exercise----[1] 6 💬
1691Other: Telerehabilitation Based LSVT BIG Exercise Protocol----[1] 6 💬
1692Other: teriflunomide[1] Teriflunomide[1] Teriflunomide 💬 [1] DHODH 💬 [1] Pyrimidine metabolism 💬[1] 13 💬
1693Other: Test du Box and Blocks----[1] 113 💬
1694Other: Test Soda----[1] 299 💬
1695Other: The Center for Neurologic Studies Bulbar Function Scale----[1] 2 💬
1696Other: The Center for Neurologic Study Bulbar Function Scale----[1] 2 💬
1697Other: The conventional balance exercise program----[1] 6 💬
1698Other: The Fatigue Severity Scale----[1] 266 💬
1699Other: The patients' parents have to complete the VINELAND II adaptive behavior scales scoring, The Sleep Disturbance Scale for Children (SDSC) and Horne & Ostberg Circadian Typology Questionnaire----[1] 149 💬
1700Other: the selected physical therapy program----[1] 149 💬
1701Other: the timed 360° turn test----[1] 6 💬
1702Other: therapeutic drug monitoring----[1] 299 💬
1703Other: Therapy Education----[1] 97 💬
1704Other: Threonine[1] Threonine[1] Threonine 💬 --[2] 96, 97 💬
1705Other: Thyroid sonography----[1] 77 💬
1706Other: Timed Up an Go Test----[1] 13 💬
1707Other: Timed Up and Go Test----[1] 6 💬
1708Other: Tissue donation after routine clinical procedure----[2] 89, 158 💬
1709Other: tissue sample----[1] 222 💬
1710Other: Tobacco questionnaire----[1] 299 💬
1711Other: Tobramycin time of administration[1] Tobramycin[2] Tobramycin ,
Tobramycin sulfate 💬 		--[1] 299 💬
1712Other: Traditional Balance Exercises----[1] 13 💬
1713Other: Training groupe----[1] 13 💬
1714Other: transcranial magnetic stimulation----[1] 6 💬
1715Other: Transthoracic echocardiography at rest, during PLR, HG and CPX (including blood gas analysis in both groups). Additionally Fallot patients will undergo routine blood testings.----[1] 215 💬
1716Other: triangular test----[1] 96 💬
1717Other: Trunk impairment----[1] 13 💬
1718Other: Trunk Impairment Scale----[1] 6 💬
1719Other: Trunk position sense----[1] 13 💬
1720Other: tyramine[1] Tyramine---[1] 6 💬
1721Other: UC-MSCs by peripheral intravenous infusion----[1] 96 💬
1722Other: Ulcerative Colitis Diet----[1] 97 💬
1723Other: Ulcerative colitis Exclusion Diet----[1] 97 💬
1724Other: Ultrasonography assessment----[1] 49 💬
1725Other: Unified Parkinson's Disease Rating Scale----[1] 6 💬
1726Other: Untreated----[1] 256 💬
1727Other: Untreated Cohort----[1] 85 💬
1728Other: Untreated contemporaneous cohort----[1] 118 💬
1729Other: Urine Collection----[2] 215, 216 💬
1730Other: urine sample----[7] 46, 49, 66, 177, 223, 240, 335 💬
1731Other: Urines samples----[1] 234 💬
1732Other: USPIO MRI - Gadolinium MRI[1] Gadolinium---[1] 13 💬
1733Other: Usual Care----[4] 13, 46, 107, 299 💬
1734Other: Usual care arm exercise----[1] 6 💬
1735Other: Usual drug treatment of Parkinson's disease----[1] 6 💬
1736Other: Usual medical management of patients, additional blood and stool samples for biobanking----[6] 40, 41, 46, 48, 53, 56 💬
1737Other: Usual Urogynecologic care----[1] 226 💬
1738Other: Valsalva----[1] 58 💬
1739Other: Vegan Diet----[1] 46 💬
1740Other: Vegetable Oil----[1] 257 💬
1741Other: Vehicle----[2] 53, 160 💬
1742Other: Vehicle (D5W or saline)----[1] 66 💬
1743Other: Vehicle Control----[2] 36, 57 💬
1744Other: Venipuncture for blood sample----[1] 18 💬
1745Other: Venous blood draw and skin biopsy----[2] 2, 13 💬
1746Other: Venous blood markers----[1] 299 💬
1747Other: Venous blood sampling----[1] 49 💬
1748Other: Ventilatory/ respiratory and other support assessment----[1] 113 💬
1749Other: Ventilatory/ respiratory, Cardiac and other support assessment----[1] 111 💬
1750Other: Vestibular habituation exercises----[1] 13 💬
1751Other: Vestibular rehabilitation: balance and eye movement exercises----[1] 13 💬
1752Other: Video-electroencephalography----[1] 140 💬
1753Other: Virtual reality group----[1] 13 💬
1754Other: Visit 1----[1] 79 💬
1755Other: Visit 2----[1] 79 💬
1756Other: Visit 3----[1] 79 💬
1757Other: Visit 4----[1] 79 💬
1758Other: Visual Acuity (VA)----[2] 90, 301 💬
1759Other: Vital signs----[1] 19 💬
1760Other: Vitamin D intake[1] Vitamin D---[1] 46 💬
1761Other: Vitamin D status[1] Vitamin D---[1] 46 💬
1762Other: Vitamin K----[1] 13 💬
1763Other: Vitamin K Cream----[1] 13 💬
1764Other: VOCs profile----[2] 96, 97 💬
1765Other: Voluntary cough test----[1] 6 💬
1766Other: Walk distance test----[1] 58 💬
1767Other: warm salt water bath[1] Water[1] Water 💬 --[1] 46 💬
1768Other: Water[1] Water[1] Water 💬 --[3] 67, 96, 240 💬
1769Other: Water or milk[1] Water[1] Water 💬 --[1] 97 💬
1770Other: water preparation[1] Water[1] Water 💬 --[1] 96 💬
1771Other: Water prescription[1] Water[1] Water 💬 --[1] 67 💬
1772Other: Water-based Liuzijue exercise[1] Water[1] Water 💬 --[1] 49 💬
1773Other: Wheat flour[1] Wheat[1] Wheat 💬 --[1] 266 💬
1774Other: WHOQOL-BREF----[1] 46 💬
1775Other: Withdraw all immunosuppresants----[1] 11 💬
1776Other: Withdrawal from alpha1 antitrypsin replacement therapy----[1] 231 💬
1777Other: Withdrawal of dalfampridine-ER 10mg[1] Dalfampridine[1] Dalfampridine 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
1778Other: Xanthan Gum[1] Xanthan gum[1] Xanthan gum 💬 --[1] 98 💬
1779Other: YTS109 cell----[4] 48, 49, 51, 53 💬
1780OTILIMAB[1] Otilimab[1] Otilimab 💬 [1] CSF2 💬 [16] Acute myeloid leukemia, Amoebiasis, Coronavirus disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬[1] 46 💬
1781Otilimab (GSK3196165)[1] Otilimab[1] Otilimab 💬 [1] CSF2 💬 [16] Acute myeloid leukemia, Amoebiasis, Coronavirus disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬[1] 46 💬
1782OTL-101----[1] 65 💬
1783OTL-103----[1] 65 💬
1784OTL-103 Dispersion for Infusion----[1] 65 💬
1785OTL-200----[1] 19 💬
1786OTL-200 Dispersion for Infusion----[1] 19 💬
1787OTL-203[1] OTL-203---[1] 19 💬
1788Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254measured as amount of total protein containing the PorA P1.4----[1] 11 💬
1789OV101----[2] 201, 206 💬
1790OV101 (gaboxadol)[1] Gaboxadol[1] Gaboxadol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 206 💬
1791OV101 Regimen 1----[1] 201 💬
1792OV101 regimen 2----[1] 201 💬
1793Ova-Treg----[1] 96 💬
1794Ovasave----[1] 96 💬
1795Ovastat 1000[1] Treosulfan[1] Treosulfan 💬 --[2] 13, 65 💬
1796Ovastat 1000 (Treosulfan injection)[1] Treosulfan[1] Treosulfan 💬 --[1] 65 💬
1797Ovastat 1000 mg, powder for solution for infusion[1] Treosulfan[1] Treosulfan 💬 --[1] 65 💬
1798Ovastat 5000[1] Treosulfan[1] Treosulfan 💬 --[2] 13, 65 💬
1799Ovastat 5000 (Treosulfan injection)[1] Treosulfan[1] Treosulfan 💬 --[1] 65 💬
1800Ovastat 5000 mg, powder for solution for infusion[1] Treosulfan[1] Treosulfan 💬 --[1] 65 💬
1801Over encapsulated prednisone[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
1802Over the counter DHA/EPA dietary supplementation----[1] 301 💬
1803Over-encapsulated 150 mg Irbesartan Tablets[1] Irbesartan[1] Irbesartan 💬 [1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 66 💬
1804Over-encapsulated 75 mg Irbesartan Tablets[1] Irbesartan[1] Irbesartan 💬 [1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 222 💬
1805Over-encapsulated Entacapone Tablets[1] Entacapone[1] Entacapone 💬 [1] COMT 💬 [3] Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬[1] 6 💬
1806Over-encapsulated Irbesartan[1] Irbesartan[1] Irbesartan 💬 [1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 222 💬
1807Over-encapsulated Irbesartan Tablets[1] Irbesartan[1] Irbesartan 💬 [1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 66, 222 💬
1808Over-encapsulated Modafinil[1] Modafinil[1] Modafinil 💬 --[1] 6 💬
1809Overactive bladder antimuscarinic deprescribing----[1] 6 💬
1810Overencapsulated Azathioprine (Imuran) 50 mg Tablet[1] Azathioprine[2] Azathioprine ,
Azathioprine sodium 💬 		--[1] 97 💬
1811Overencapsulated mesalazine tablets[1] Mesalazine[1] Mesalamine 💬 --[1] 97 💬
1812Overencapsulated Prednisolone Tablets[1] Prednisolone[1] Prednisolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
1813Ovine Corticotropin-Releasing Hormone (oCRH)[1] Corticotropin[2] Corticotropin ,
Corticotropin, repository 💬 		[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75 💬
1814Oxabact[1] Oxabact---[1] 234 💬
1815Oxabact (tm) - Oxalobacter formigenes strain HC1[1] Oxabact---[1] 234 💬
1816Oxabact - Oxalobacter formigenes, strain HC-1[1] Oxabact---[1] 234 💬
1817Oxabact OC5 - Oxalobacter formigenes HC-1[1] Oxabact---[1] 234 💬
1818Oxabact OC5 - Oxalobacter formigenes Strain HC-1[1] Oxabact---[1] 234 💬
1819Oxabact OC5 capsules[1] Oxabact---[1] 234 💬
1820Oxabact(tm) - Oxalobacter formigenes, strain HC1[1] Oxabact---[1] 234 💬
1821Oxabact_Oxalobacter formigenes strain HC-1----[1] 234 💬
1822Oxabact_Oxalobacter formigenes, strain HC-1----[1] 234 💬
1823Oxabacter formigenes, strain HC1----[1] 234 💬
1824Oxacom----[1] 86 💬
1825Oxadrop----[1] 96 💬
1826Oxalate decarboxylase----[1] 234 💬
1827Oxaloacetate----[1] 11 💬
1828Oxaloacetate (OAA)----[1] 6 💬
1829Oxaloacetic Acid[1] Oxaloacetic acid---[1] 2 💬
1830Oxalobacter formigenes----[1] 234 💬
1831OXALOBACTER FORMIGENES, STRAIN HC 1----[1] 234 💬
1832Oxalobacter formigenes, strain HC-1[1] Oxabact---[1] 234 💬
1833Oxalobacter formigenes, strain HC1[1] Oxabact---[1] 234 💬
1834OXALOBACTERFORMIGENES,STRAINHC1----[1] 234 💬
1835Oxaluria evolution.----[1] 234 💬
1836Oxandrolone[1] Oxandrolone[1] Oxandrolone 💬 [1] AR 💬 [4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[2] 211, 285 💬
1837Oxanest----[1] 70 💬
1838Oxatomide[1] Oxatomide[1] Oxatomide 💬 [1] ALOX5 💬 [6] Arachidonic acid metabolism, Efferocytosis, Fc epsilon RI signaling pathway, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬[1] 113 💬
1839Oxatomide (tinset)[1] Oxatomide[1] Oxatomide 💬 [1] ALOX5 💬 [6] Arachidonic acid metabolism, Efferocytosis, Fc epsilon RI signaling pathway, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬[1] 113 💬
1840OXB-102----[1] 6 💬
1841Oxcarbazepine[1] Oxcarbazepine[1] Oxcarbazepine 💬 [6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 13 💬
1842Oxepa----[1] 2 💬
1843OXERVATE----[1] 53 💬
1844OXICODONE DC.IT----[1] 46 💬
1845Oxiconazole[1] Oxiconazole[2] Oxiconazole nitrate ,
Oxiconazole 💬 		--[1] 160 💬
1846Oxiklorin----[2] 13, 46 💬
1847OXITRIPTAN[1] Oxitriptan[1] Oxitriptan 💬 --[1] 97 💬
1848OXN 10 mg / 5 mg PR----[1] 6 💬
1849OXN 10/5 mg PR----[1] 226 💬
1850OXN 20 mg / 10 mg PR----[1] 6 💬
1851OXN 20/10 mg PR----[1] 226 💬
1852OXN 5 mg/2.5 mg PR----[1] 6 💬
1853OXN 5/2.5 mg PR----[1] 226 💬
1854OXY-001----[1] 46 💬
1855Oxybuprocaine[1] Oxybuprocaine[2] Benoxinate hydrochloride ,
Oxybuprocaine 💬 		[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 6 💬
1856Oxybutynin[1] Oxybutynin[2] Oxybutynin ,
Oxybutynin chloride 💬 		[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[3] 6, 13, 53 💬
1857Oxybutynin and darifenacin[2] Darifenacin,
Oxybutynin		[4] Oxybutynin ,
Oxybutynin chloride ,
Darifenacin hydrobromide ,
Darifenacin 💬 		[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 6 💬
1858Oxybutynin hydrochloride[1] Oxybutynin[2] Oxybutynin ,
Oxybutynin chloride 💬 		[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[2] 6, 13 💬
1859Oxybutynin, tolterodine, solifenacin[3] Oxybutynin,
Solifenacin,
Tolterodine		[6] Oxybutynin ,
Tolterodine ,
Oxybutynin chloride ,
Tolterodine tartrate ,
Solifenacin succinate ,
Solifenacin 💬 		[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 53 💬
1860OXYCODO----[1] 6 💬
1861Oxycodone[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[7] 6, 13, 46, 70, 226, 231, 298 💬
1862Oxycodone by patient-controlled analgesia (PCA)[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 46 💬
1863Oxycodone Depot ”Sandoz”, depot tablets[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 298 💬
1864OXYCODONE HYDROCHLORIDE[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[4] 6, 70, 226, 298 💬
1865Oxycodone naloxone prolonged release tablets[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
1866Oxycodone Orion[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 70 💬
1867Oxycodone/Acetaminophen[2] Acetaminophen,
Oxycodone		[4] Acetaminophen ,
Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		[5] OPRD1,
OPRK1,
OPRM1,
PTGS1,
PTGS2 💬 		[30] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Estrogen signaling pathway, Hormone signaling, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Sphingolipid signaling pathway, TNF signaling pathway, VEGF signaling pathway, cGMP-PKG signaling pathway 💬[1] 231 💬
1868Oxycodone/naloxone prolonged release t[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
1869Oxycodone/Naloxone Prolonged Release tablets[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
1870Oxycodone/naloxone prolonged release tablets 10 mg /5 mg[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
1871Oxycodone/naloxone prolonged release tablets 10/5 mg[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
1872Oxycodone/naloxone prolonged release tablets 20 mg /10 mg[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
1873Oxycodone/naloxone prolonged release tablets 20/10 mg[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
1874Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
1875Oxycodone/naloxone prolonged release tablets 5/2.5 mg[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
1876Oxycodonhydrochlorid ”Lannacher”, depot tablets----[1] 298 💬
1877Oxycontin LP 10mg----[1] 6 💬
1878Oxycontin LP 20mg----[1] 6 💬
1879Oxycontin LP 5mg----[1] 6 💬
1880Oxygen[1] Oxygen[1] Oxygen 💬 --[30] 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
1881Oxygen 40 %[1] Oxygen[1] Oxygen 💬 --[1] 85 💬
1882Oxygen flow at the optic nerve head measurement[1] Oxygen[1] Oxygen 💬 --[1] 19 💬
1883Oxygen Gas for Inhalation[1] Oxygen[1] Oxygen 💬 --[2] 96, 97 💬
1884Oxygen Medicinal Gas SOL 100% v/v medicinal gas, compressed[1] Oxygen[1] Oxygen 💬 --[1] 97 💬
1885Oxygen supplementation[1] Oxygen[1] Oxygen 💬 --[1] 86 💬
1886Oxygen, liquid[1] Oxygen[1] Oxygen 💬 --[2] 86, 88 💬
1887Oxygen, medical gas[1] Oxygen[1] Oxygen 💬 --[1] 211 💬
1888Oxygen-15 Water[2] Oxygen,
Water		[2] Water ,
Oxygen 💬 		--[1] 6 💬
1889Oxyhydrogen nanobubble infusion----[1] 6 💬
1890Oxymatrine[1] Oxymatrine---[1] 37 💬
1891Oxynorm----[1] 298 💬
1892Oxytocin[1] Oxytocin[1] Oxytocin 💬 [1] OXTR 💬 [5] Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[8] 6, 70, 72, 127, 168, 193, 206, 226 💬
1893Oxytocin (OXT) continuous[1] Oxytocin[1] Oxytocin 💬 [1] OXTR 💬 [5] Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[1] 193 💬
1894Oxytocin 24IU[1] Oxytocin[1] Oxytocin 💬 [1] OXTR 💬 [5] Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[1] 206 💬
1895Oxytocin 48IU[1] Oxytocin[1] Oxytocin 💬 [1] OXTR 💬 [5] Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[1] 206 💬
1896Oxytocin nasal spray[1] Oxytocin[1] Oxytocin 💬 [1] OXTR 💬 [5] Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[3] 70, 72, 193 💬
1897OXYTOCIN SYNTHETIC[1] Oxytocin[1] Oxytocin 💬 [1] OXTR 💬 [5] Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1898Oyster[1] Oyster---[1] 84 💬
1899Ozanezumab[1] Ozanezumab[1] Ozanezumab 💬 [1] RTN4 💬 [1] Alzheimer disease 💬[1] 2 💬
1900Ozanimod[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 13, 96, 97 💬
1901Ozanimod 0.5 mg[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
1902Ozanimod 1 mg[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
1903Ozanimod Cloridrato[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
1904Ozanimod HCI[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
1905Ozanimod HCL[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 13, 96, 97 💬
1906Ozanimod hydrochloride[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 13, 96, 97 💬
1907Ozanimod Oral Capsule[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 97 💬
1908Ozonated olive oil[1] Olive oil[1] Olive oil 💬 --[2] 35, 162 💬
1909Ozone[1] Ozone---[5] 49, 51, 70, 71, 226 💬
1910Ozoralizumab[1] Ozoralizumab[1] Ozoralizumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬